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ABSTRACT 
The Ca
2+
-dependent protease calpain-1 has been found constitutively present in lipid 
raft/caveolin-1 membrane microdomains isolated from endothelial bEnd5 cells. In this 
membrane localization calpain-1 is associated with some of its substrates, such as endothelial 
Nitric Oxide Synthase (eNOS) and the chaperone Heat Shock Protein 90 (HSP90), whereas the 
calpain-2 and the inhibitor calpastatin have not been detected.  
Alteration in intracellular Ca
2+
 homeostasis, induced by either treatment with Ca
2+
-
ionophore A23187 or prolonged cell exposure to high glucose, leads to a signiﬁcant decrease in 
the level of eNOS associated to lipid rafts, followed by a recruitment of HSP90 at this site. The 
decrease of eNOS is due not only to its Ca
2+
-dependent release from the caveolin-1 
microdomains, but also to its digestion mediated by calpain-1. The speciﬁc involvement of 
calpain-1 in digestion of eNOS is supported by the preventive effect of a synthetic calpain 
inhibitor (CI-2). However, the modifications observed in lipid rafts protein composition make 
bEnd5 cells more resistant against cell death caused by Ca
2+
 overload. In this context, calpain-1 
seems to play a protective role against NO overproduction. 
 Alterations in eNOS, calpain-1 and HSP90 levels have been also detected in aorta of 
Zucker Diabetic Rats (ZDR). The digestion of HSP90 indicates an aberrant activation of calpain, 
due to a chronic alteration in Ca
2+
 homeostasis occurring in these animals, and thereby the 
transition from a physiological to a pathological cell condition. These changes cannot be detected 
in brain cortex, suggesting a tissue-specificity of the alteration in Ca
2+
 homeostasis related to 
diabetes. 
A similar protein organization of lipid rafts has been also observed in neuroblastoma SK-
N-BE cells, where calpain-1 is associated with NMDAR, HSP90 and neuronal NOS (nNOS), as 
well as in brain cortex of normotensive rats. Preliminary results have demonstrated that the 
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increase in [Ca
2+
]i, that characterizes the nervous tissue of hypertensive rats,  leads to a protein 
reorganization of the lipid rafts.  
The results presented in this thesis provide new information on a selective localization and 
role of calpain-1. In endothelial cells the protease and its associated substrates seem to have a 
crucial role in responding to fluctuations of [Ca
2+
]i. Further investigations will be necessary to 
analyse the role of the protease associated to lipid rafts in nervous tissue both in physiological 
and pathological conditions.  
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1. INTRODUCTION 
1.1 Calpains  
Calpains are a group of intracellular Ca
2+
-dependent cysteine endopeptidases, which have 
been identified in almost all eukaryotes and bacteria, but not in archaebacteria. In humans, this 
group of enzymes includes 15 isoforms, some of which are present ubiquitously and other ones 
show a tissue-specific pattern of expression [1]. First identified in 1964, calpains take their name 
from calmodulin and papain that share some functional aspects and part of the amino acid 
sequence [2, 3]. Calpains are implicated in many pathological and physiological processes such 
as cytoskeletal remodelling, cell proliferation, migration, invasion, apoptosis and signal 
transduction [1, 2]. Following activation, calpains can catalyse the proteolytic processing of a 
large number of intracellular proteins leading to modification of cell behaviour and viability. 
Because the enzyme participates not only in normal intracellular signal transduction cascades, 
but also in various pathological states, the study of calpains has aroused great interest in wide 
areas of life sciences in both basic and clinical research in the last decades [3]. However, the 
physiological importance of calpains remains to be established. The involvement of calpains 
activity in various pathophysiological events has been reported, but usually as an aggravating 
factor. Although it is commonly accepted that the regulation of calpains is critical for 
maintenance of normal cell functions, uncertainties remain regarding when and how these 
enzymes undergo activation [2]. Genetic techniques have demonstrated the cause-effect 
relationships between calpain deficiency and defective tissue functions. These conditions, named 
“calpainopathies” are often incompatible with cell survival, demonstrating the physiological 
importance of calpains [2]. It is now clear that calpains are endowed with functional properties 
different from those that characterise other main intracellular proteolytic components such as 
proteasomes, caspases and autophagy. First of all, the digestion of calpains substrates, which 
generally occurs in a limited and selective manner, is considered a “proteolytic processing” since 
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the target protein does not undergo extensive degradation but often acquires novel functional 
properties. Furthermore, calpains do not require any protein modification or tag to recognize and 
hydrolyse the peptide bonds present in the consensus sequences of its substrates themselves are 
involved in substrates recognition [2].  
The conventional members in the superfamily of calpains are heterodimers with different 
80 kDa catalytic large L-subunits and 30 kDa regulatory small S-subunits. In humans, 15 genes 
code for the L-subunits (CAPN1, CAPN2, CAPN3, CAPN5, …, CAPN16) and 2 genes code for 
S-subunits (CAPNS1, also called CAPN4, and CAPNS2) [2]. The gene products of 
CAPN1/CAPNS1 and CAPN2/CAPNS1 are named calpain-1 and calpain-2, respectively. These 
heterodimers share the same 30 kDa regulatory subunit, but each one has a different 80 kDa 
catalytic subunit. These two calpains, which are the best characterized forms, are ubiquitous 
(only erythrocytes lack calpain-2) and are distinguished by the calcium requirement to undergo 
in vitro activation. In fact calpain-1 (also known as µ-calpain) needs 5 - 20 µM Ca
2+
, while 
calpain-2 (also known as m-calpain) needs 400 – 800 µM Ca2+ [2]. CAPN1 and CAPN2 contain 
four domains/regions: the N-terminal anchor helix region, the CysPc Protease Core domain (PC1 
and PC2), the C2 domain-like domain (C2L), and the penta-EF-hand domains (PEF(L)). 
CAPNS1 contains an N-terminal Gly-rich (GR) domain and a penta-EF-hand domain (PEF(S)) 
[2]. The domains structure of the catalytic subunits of the conventional calpains, CAPN1 or 
CAPN2, is defined as “classical” and includes the C2L, the PEF and the CysPc domain. 
Alternatively, “non-classical” calpains exclude C2L and/or PEF domains [2]. Nine out of 15 
calpain genes encode the “classical” or “conventional” calpains, CAPN1, CAPN2, CAPN3, 
CAPN8, CAPN9, CAPN11, CAPN 12, CAPAN 13 and CAPN14, whereas CAPN5, CAPN6, 
CAPN7, CAPN10, CAPN15 and CAPN16 are defined as “non-classical” calpains [2]. The 
ubiquitous calpains, CAPN1, CAPN2 (except in erythrocytes), CAPN5, CAPN7, CAPN10, 
CAPN13, CAPN14, CAPN15, CAPN16, CAPNS1 and CAPNS2,  play an essential role in all 
cells, in fact, defects in these isoforms may be lethal, as seen in Capn2
−
/
−
 or Capns1
-
/
-
 knockout 
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mice [2, 4]; whereas the tissue-specific calpains, CAPN3, CAPN6, CAPN8, CAPN9, CAPN11 
and CAPN12 are involved in more specific cellular functions and their defects may cause tissue-
specific phenotypes, such as muscular dystrophy caused by mutations in CAPN3 [2, 5].  
 
 
 
 
 
 
 
 
 
 
 
 
The catalytic mechanism of calpain is common to other cysteine-proteases, serine-
proteases and threonine-proteases and depends on three amino acids collectively named 
“catalytic triads” [6]. In calpain the residue used as a nucleophile is the oxidized sulfur of the 
cysteine. In addition, the basic and acid residues needed for catalysis are provided by an histidine 
and an aspartate, respectively [7].  
The physiological role of calpains is related to extracellular signals transduction mediated 
by changes in the permeability of the plasma membranes to Ca
2+
 or by the mobilization of this 
ion from intracellular stores. Indeed, the structural transitions of calpain during its activation 
process are triggered by Ca
2+
 addition [8]. The crystallographic analysis of the enzyme structure 
and the studies of the kinetics of Ca
2+
 binding have demonstrated that the onset of proteolytic 
activity appears only after a delay. This delay has been attributed to a Ca
2+
-induced 
Figure 1: Schematic structure of calpain. Conventional calpains 
are composed of large catalytic and small regulatory subunits. 
Adapted from [2].  
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conformational change making the active site of the enzyme accessible to the substrate. 
Furthermore, it has been demonstrated that Ca
2+
 causes the dissociation of the heterodimeric 
native calpain into its constitutive L- and S-subunits, with increased Ca
2+
 affinity than the native 
form, thereby yielding the active form of the protease [8, 9]. In the absence of Ca
2+
 the amino 
acid residues of the active site, which are crucial for the proteolytic activity, are not correctly 
positioned with respect to the substrate binding site, suggesting the requirement for a 
conformational change leading to the active form. Several studies have reported that the binding 
of Ca
2+ 
causes an electrostatic switch, inducing a structural rearrangement of the active site 
leading to a correct positioning of the catalytic triad [8]. Indeed, the primary event in the 
activation process corresponds to the binding of Ca
2+
 to eight interacting sites, four in each of the 
two subunits, localized in calmoduline-like regions. Progressive binding of Ca
2+
 ions is linearly 
correlated with the dissociation of the heterodimeric enzyme, which reaches completion when all 
the binding sites are occupied [9].  
Exposure to Ca
2+
 also induces calpain autoproteolysis. The 80 kDa calpain subunit, in 
presence of Ca
2+
, undergoes intramolecular autoproteolysis that, by the removal of a peptide 
from the N-terminus, generates a 75 kDa species with an increased affinity for Ca
2+
. Thus, such 
autoproteolytic event contributes to make the active site accessible to the substrate [9, 10]. An 
important question in the field of calpain research concerns the remarkable inconsistency of Ca
2+
 
requirement necessary to activate the enzyme in vitro and the intracellular availability of this 
metal ion. In fact, although μM concentrations of Ca2+ are sufficient to activate purified calpain-
1, the physiological amounts of cytosolic Ca
2+
 are in the range of 50 – 300 nM [11]. Since in 
vitro experiments have demonstrated that phospholipids, the most abundant type of lipid 
constituents in the cell membranes, lowered the Ca
2+
 requirement necessary to activate the 
protease, it has been proposed that microdomains close to the plasma membrane could represent 
favourable locations for the calpain activation. It has been also proposed that a limited amount of 
calpain, whose localization coincides with the spots where cell Ca
2+
-concentration substantially 
9 
 
increases, is sufficient to maintain its physiological function [1]. The isolated 80 kDa catalytic 
subunit of calpain shows a 2-fold increased affinity for Ca
2+
 than the native heterodimeric form. 
However, only the autoproteolized 75 kDa form of the catalytic subunit shows a 20-fold 
increased affinity for Ca
2+
, reaching a Kd closer to the physiological Ca
2+ 
concentration [9].  
An extensive literature suggests that calpains participate in a variety of cellular functions 
such as remodelling of cytoskeletal/membrane attachments during cell fusion and motility, 
processing of proteins involved in the control of the cell cycle, gene expression and apoptotic 
pathways [11]. However, the physiological functions of the calpain system and its regulation in 
living cells is not still completely defined. Moreover, the identification of some calpain isoforms 
lacking the amino acid residues necessary for catalysis suggests that in some circumstances 
calpains may play functions alternative to the proteolytic activity [11]. Aim of this thesis is to 
add information about the mechanism responsible of the intracellular regulation of the calpain 
proteolytic system. Many investigations have attempted to define the physiological functions of 
calpain using several different protease inhibitors in order to identify the cell functions affected. 
However, most of the inhibitors used are not absolutely specific for the calpains and effect the 
functions of other enzymes or have aspecific secondary effects. Consequently, the results of 
experiments based on the use of calpain inhibitors should be interpreted cautiously [11]. One of 
the best approaches available for studying the  physiological functions of calpains is knocking 
out calpains genes. This allowed, for example, to determine that the 30 kDa regulatory subunit 
(Capn4) is crucial for animal vitality, since its lack causes a lethal phenotype in the mouse 
embryo. On the other hand, calpain-1 deletion only interferes with the platelets functioning and 
the coagulative process, but is not essential for mouse survival. Although it is commonly 
accepted that calpain-1 is involved in degradation of filamin, talin, and spectrin during platelet 
activation, the cleavage patterns and kinetics of degradation of both talin and filamin are normal 
in platelets from the Capn1
-
/
-
 mice [11]. This finding supports the hypothesis that calpain-2, 
although present in very low amounts in mouse platelets, can digest the same substrates, 
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compensating for the absence of calpain-1. Instead, the role of calpain-2 in mouse embryonic 
development is absolutely crucial, because the deletion of Capn2 leads to a lethal phenotype 
already at a very early stage of gestation, suggesting that its essential functions cannot be 
compensated by calpain-1 [11].   
Several studies have demonstrated that calpains are responsible for degradation of various 
cytoskeletal proteins implicated in cell division, cell motility or platelets activation. Implication 
of calpains in cytoskeletal remodelling is also related to their role in cytoskeletal/membrane 
interactions. For example, the β-integrin family of integrins is substrate of calpains. Integrin 
clustering or binding of ligands to specific receptors leads to calpain activation. Calpain 
mediated cleavage of both integrins and cytoskeletal proteins in focal contacts interferes with the 
interactions among these proteins resulting in disassembly of focal adhesions, cell rounding, loss 
of actin filament networks, increased rates of cell motility, and, in platelets, retraction of fibrin 
clots [11]. Calpains also participate in various signal transduction pathways through the cleavage 
of many phosphatases and kinases, such as PKC which becomes constitutively active after a 
limited proteolytic event catalysed by calpain. Moreover, calpains also participate in cell cycle 
regulation, through digestion of ciclin D1, that prevents mitosis and digestion of the tumor 
suppressor p53. Indeed, using synthetic calpain inhibitors it is possible to arrest the cell 
proliferation at the G1 phase with a substantial increase of the level of p53 [11]. The 
involvement of calpains in the regulation of gene expression has not been fully clarified. In fact, 
calpain is able to degrade several transcription factors, such as c-Jun, c-Fos or the 
aforementioned p53. However, if the calpains are effectively involved in digestion of 
transcription factors, this event occurs likely in the cytosol, because immunolocalization studies 
indicate that calpains are not generally located within the nucleus [11]. The participation of 
calpains to apoptosis seems limited to specific cell types, but these studies have been based on 
the use of synthetic inhibitors which often are not specifically directed towards calpain 
cathepsin, and proteasome. The use of combinations of proteasome inhibitors, cathepsin 
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inhibitors, and caspase inhibitors has not yet defined the precise role of calpains in this process. 
The understanding of the role of calpains in apoptosis is further complicated by the apparent 
ability of the calpains to cleave the caspases themselves as well as several proteins that regulate 
the progression of apoptotic steps. In some conditions, calpains may operate as a negative 
modulator of apoptosis through inactivation of caspases, whereas in other instances, they may 
work as positive regulators. This ambiguity suggests that the role of the calpains in apoptosis is 
highly cell and pro-apoptotic signal dependent [11].  
In the last years, the putative involvement of calpains in a broad range of diseases has been 
the subject of many studies. Although calpains play a role in several pathological conditions such 
as neurodegenerations, ophthalmic diseases, cancer, myopathies, ischemic diseases, diabetes and 
endothelial dysfunction [1, 11, 12], only in a few cases mutations in the calpains genes cause 
clear pathological states, such as calpain-3 related muscular dystrophy, tumorigenesis associated 
to downregulation of calpain-9, or type 2 diabetes related to calpain-10. In most of these calpain-
associated pathologies, the calpains do not represent the genetic cause. Instead, loss of Ca
2+
 
homeostasis in cell can lead to a deregulation of calpain activity, accompanied by degradation of 
calpain substrates. Although it has been shown that calpain inhibitors can prevent or delay the 
onset of calpain-associated pathologies, these studies have been usually based on the use of 
synthetic inhibitors that are not completely specific for calpains and often cannot be used in vivo 
[11]. The increase in intracellular Ca
2+
 concentration that occurs in these pathological conditions 
is generally not sufficient to induce proteolytic activity of calpains, especially of  the high Ca
2+
 
requiring calpain-2. In some instances, Ca
2+
 may reach levels that could activate calpain-1 but, 
rather than activating calpains directly, it seems more likely that the alteration of Ca
2+
 
homeostasis affects the regulation of calpain activity [11].  
Different cells and different signalling pathways involve either calpain-1 or -2 but not both, 
and the two isoforms can play different roles in the same cell depending on the signal that the 
cell receives [11]. Calpain-1 and calpain-2 have been detected in almost every vertebrate cell, but 
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different tissues/cells differ widely in their ratios. For example, human platelets and erythrocytes 
have no detectable calpain-2, whereas bovine platelets and vascular smooth muscle have no 
detectable calpain-1 and skeletal muscle contains comparable amounts of the two isozymes [11]. 
It is possible that calpain-1 and -2 can perform similar physiological functions but in response to 
different cellular stimuli, also because of their different Ca
2+
 requirement. In fact, they have 
analogous specific cleavage sites, although often on different substrates. Previous studies 
revealed that calpain-1 and -2 are predominantly distributed in the cytosol, with a modest 
predominance around the nuclear region in cell resting conditions. Immunolocalization studies 
showed that in human erythrocytes 93% of the calpain is cytosolic and the remaining 7% is 
associated with the plasma membrane. In response to Ca
2+
 signaling, calpains translocate to the 
plasma membrane, identified as a cell site suitable for their activation [11, 13]. Several studies 
have suggested that a considerable fraction of calpains are not free in the cytosol, but rather 
associated with subcellular structures. In the skeletal muscle these structures are myofibrils, 
whereas in other cells they may be cytoskeletal filaments [11]. It has been estimated that, in a 
skeletal muscle cell, the concomitant activation of all calpain molecules could destroy some 
components of sarcomere, such as the Z-disks in less than 5 minutes. Consequently, in living 
cells calpain must be finely regulated not only by its Ca
2+
 requirement, but also by changes in its 
intracellular location, accessibility to substrates, and also by phosphorylation as shown for 
calpain-2 inactivation by PKA mediated phosphorylation [14]. In addition, it has been clearly 
established that calpain activity is also regulated by its natural protein inhibitor, calpastatin [11]. 
 
1.2 Calpastatins 
Calpastatin, that does not share any sequence homology to any other protein, has been 
identified as the unique endogenous inhibitor specific for conventional calpains [15]. It is an 
approximately 120 kDa heat-stable protein resistant to a broad variety of denaturing agents and 
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ubiquitous in mammalian tissues. Different promoters or alternative splicing mechanisms allow 
each cell to produce different calpastatin polypeptides from a single gene. How many different 
start sites of transcription or translation might be used in different tissues or under different 
physiological states remain to be elucidated [11]. At present four main types of calpastatin with 
different N-terminal sequences and other four isoforms with internal deletions generated by 
alternative splicing have been identified. The various calpastatin forms show different inhibition 
efficiency. However, the physiological significance of the at least eight calpastatin isoforms is 
still unclear. [11, 16]. 
 The full-length calpastatin contains a N-terminal XL-domain, followed by a L-domain and 
four repetitive inhibitory domains (I-IV domains) [16]. Three highly conserved regions, termed 
A, B and C, are present in the four repetitive inhibitory domains. Each of these conserved 
regions is able to interact preferentially with different calpain domains. Particularly, region B, 
interacting with the active site of calpain, seems to be the inhibitory centre of calpastatin, 
whereas regions A and C potentiate the inhibitory activity [2, 15, 16]. Each inhibitory domain 
can inhibit one calpain molecule, hence, potentially, calpastatin can simultaneously bind and 
inhibit four calpain molecules. Both the XL- and L-domain lack inhibitory activity. Their 
function is not yet completely clear, but it has been proposed that they can play a regulatory role 
on calpain-calpastatin interaction [17].      
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Figure 2: Schematic structure of the full-length calpastatin.     
The conserved 12-amino acid sequence in B-region 
(GxxE/DxTIPPxYR) is essential for inhibitory activity. Adapted 
from [2].  
 
 
 
 
 
 
 
 
 
 
 
 
 
The interaction between calpain and calpastatin can occur in the absence of Ca
2+
 or at very 
low Ca
2+
 concentrations, reflecting the in vivo conditions and depending on the molecular 
structure of the calpastatin isoform involved. The L-domain seems to play a regulatory role on 
calpain activation [18]. A Ca
2+
-independent association of the calpain-calpastatin complex can 
occur through a binding sequence localized in the L-domain of calpastatin. Conversely, the 
absence of L-domain makes this protein-protein interaction strictly Ca
2+
-dependent [19]. 
Because the concentration of Ca
2+
 required for calpain-calpastatin association is lower than that 
required by calpains to initiate their proteolytic activity, and because immunolocalization studies 
suggest that calpains and calpastatin are frequently co-localized in cells, somehow cells must be 
able to allow calpain activation, even in the presence of its inhibitor [11]. Some of the 
mechanisms proposed to obtain this result involve the translocation of the calpain away from 
calpastatin or the reduction of Ca
2+ 
requirement for calpain activation without affecting Ca2+ 
requirement for calpastatin binding. Furthermore, phosphorylation of calpastatin has been also 
reported as a post-translational mechanism to control the functional role of calpastatin. Hence, it 
is possible to hypothesize that different combinations of calpastatin phosphorylation/calpain 
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phosphorylation might completely prevent calpastatin binding and calpain inhibition at 
concentrations of Ca
2+
sufficient for calpain activation [11, 15].  
In addition to its role as calpain inhibitor, calpastatin is also a potential substrate of the 
enzymes. The calpains mediated limited digestion of native calpastatin, can result in the release 
of four still active inhibitory units that, by amplifying the cell inhibitory capacity, can play a 
crucial role in controlling calpain activation in cells with an altered Ca
2+
 homeostasis [17]. 
Indeed, the four free repetitive inhibitory domains of calpastatin are potentially available to 
counteract aberrant calpain activity [17]. Hence, this conservative process could represent a 
defence mechanism against the onset of an uncontrolled degradation of intracellular calpain 
substrates. The proteolysis of calpastatin has been mostly detected under conditions of excessive 
or prolonged [Ca
2+
]i dysregulation, such as in neurodegenerative diseases [17]. However, in 
pathologies related with Ca
2+ 
alteration, overexpression of calpastatin inhibitory units 
successfully prevents the excessive digestion of calpain targets [19, 20].  
Under resting conditions, calpastatin appears homogenously distributed in cytosol, with a 
discrete preponderance around the nuclear region, but also in nucleus or in nuclear invaginations 
[13]. Hood et al have reported that calpastatin and the two ubiquitous calpain isoforms are 
associated with subcellular organelles, such as endoplasmic reticulum and Golgi apparatus [21]. 
After a stimulation that increases the intracellular Ca
2+ 
concentration, calpastatin, unlike calpain, 
does not translocate to plasma membrane [13]. This dissociation of calpain from its inhibitor 
allows the protease activation and the cleavage of its substrates [21].       
 
1.3 Interaction between calpain-1 and a few of its substrates  
To fulfil its physiological functions calpain requires specific recognition of digestible 
substrates, selective cellular localization and proper mechanisms for regulating its activation and 
activity. It has been reported that an aliquot of calpain-1 is permanently associated to 
16 
 
multiprotein complexes in plasma membrane, where the protease is involved in the regulation 
and turnover of both enzymes and channels/receptors, such as the N-Methyl-D-Aspartate 
Receptor (NMDAR) [22, 23], one of the three types of ionotropic glutamate receptors, 
possessing an intrinsic ion channel. Its activation requires simultaneous binding of the two 
agonists glutamate and glycine along with membrane depolarization, but the receptor can be also 
activated by several endogenous and exogenous agonists [23]. NMDAR is implicated in various 
physiological functions in the nervous system, such as synaptic plasticity and memory function, 
but it is also involved in neurological diseases, such as epilepsy, ischemia, stroke and 
neurodegenerative disorders. [23]. NMDAR has been identified as a calpain target by several in 
vitro and in vivo studies. The receptor activation leads to entrance of Ca
2+
 into the cells followed 
by several down-stream intracellular events, including calpain activation. Over-stimulation of 
NMDAR causes an excessive influx of Ca
2+
, which can lead to excitotoxicity [22, 23]. NMDAR 
is a heterotetrameric channel constituted of four subunits, usually two NR1 and two NR2 
subunits. The NR1 subunit is not a calpain target, whereas the NR2 A-C subunits can be cleaved 
at the C-terminal region by calpain-1. The NR2 amino-terminal fragment produced by calpain-1 
is still able to associate with NR1, forming a functional receptor [23]. However, Averna et al 
have reported that the digestion of NR2B subunit leads to its internalization into vesicles, 
together with NR1 [22]. While in resting conditions small amounts of NMDAR are detectable in 
intracellular membranes, following NMDAR stimulation most of the receptor molecules are 
internalized [22]. By digesting NMDAR and other associated intracellular proteins, calpain-1 can 
regulate the physiology of glutamatergic transmission. Consequently, it is plausible that, in 
pathological conditions, such as neuronal glutamate excitotoxicity, the activated protease can 
decrease the cell Ca
2+
 influx through this channel by promoting the removal of NMDAR from 
the plasma membrane. Thus, calpain-1 mediated cleavage might also have neuroprotective 
effects against NMDAR over-activation [22, 23].  
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The chaperone Heat Shock Protein 90 (HSP90) has been identified as a protein able to 
control calpain-1 activity [24]. HSP90 is a homodimeric ATPase, which contributes to the 
correct maturation and folding of a large variety of newly synthesized polypeptides and of 
several denatured or misfolded client proteins [25]. HSP90, interacting with calpain-1, but not 
with calpain-2, forms a complex in which the protease retains its catalytic activity, but acquires a 
reduced affinity for Ca
2+
. Thereby, HSP90 participates in in regulating the activation of the 
protease [22, 24]. This could represent an alternative intracellular mechanism for the control of 
the protease, that operates near the plasma membrane, a site where calpastatin is not detectable. 
In fact, it has been demonstrated that in resting human leukemic T cells (JA3), cytosolic calpain-
1 is associated with HSP90, and the chaperone competes with calpastatin for association to the 
protease. Thus, two different complexes can be produced in the cell: the first one containing 
calpain-1 and calpastatin, in which both calpain proteolytic activity and translocation to the 
internal surface of the plasma membrane do not occur; the second one containing calpain-1 and 
HSP90, in which calpain partially retains its activity and its trafficking is not impaired [24]. The 
formation of the complex between HSP90 and calpain-1 can prevent the total inhibition of 
calpain-1, leaving the protease free from calpastatin restriction. This occurrence could explain 
how calpain-1 can translocate and express proteolytic activity in vivo, although the amount of 
calpastatin largely exceeds that of calpain [24]. HSP90 is also inserted in the multiprotein 
NMDAR cluster, where the chaperone seems to control the physiological amount and activity of 
the resident calpain-1. However, HSP90 is also a calpain-1 substrate and a prolonged or intense 
calpain activation leads to the degradation of the chaperone [26]. The specific assembly of the 
calpain substrates with other regulatory proteins in membrane clusters could represent a valid 
model to explain how calpain can reach these structures, catalysing a selective, limited and 
controlled proteolysis [24]. 
Moreover, several reports have indicated that HSP90 and calpain-1 also participate in the 
Nitric Oxide Synthase (NOS) activation pathway [26-28]. NOSs are a family of Ca
2+
-dependent 
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enzymes which catalyse the production of Nitric Oxide (NO) from L-arginine and oxygen. Three 
distinct isoforms have been identified in mammals: neuronal (nNOS or NOS-1), inducible (iNOS 
or NOS-2) and endothelial (eNOS or NOS-3) [29, 30]. NO is an essential cellular signalling 
molecule, which has multiple paracrine functions, depending on the cell type which synthetize 
NO, the NOS isoform involved and the causal chain of events responsible of the NO production 
[30]. The neuronal isoform of NOS is a 155 kDa protein distributed both in the cytosol and 
associated with the plasma membrane. nNOS is constitutively expressed in nervous tissues, 
where it synthetizes NO in response to glutamate. nNOS is involved in synaptic plasticity, 
smooth muscle relaxation, central regulation of blood pressure and it also plays a role in cell 
communication [30, 31]. This enzyme is also involved in hypoxic or ischemic processes, playing 
either a neurotoxic or a neuroprotective role. Indeed, NO over-production may be neurotoxic, 
leading to the production of Reactive Oxygen Species (ROS), excitotoxicity, inflammation, 
apoptosis and brain injury [31]. The endothelial NOS is a 135 kDa protein constitutively 
expressed by vascular endothelial cells and it is predominantly associated to the plasma 
membrane. eNOS is mainly involved in vasodilation and it is activated in response to 
acetylcholine [30, 31]. eNOS can play both a vasoprotective and a neuroprotective role in 
ischemic processes, contributing to maintain a proper blood flow and preventing vascular injury. 
Diminished NO production has been implicated in pathogenesis of hypertension and in vascular 
disorders, such as atherosclerosis [31, 32]. The inducible NOS is a 130 kDa enzyme and, unlike 
the other two isoforms, is Ca
2+
-independent. Following its identification in rat macrophages, 
predominantly distributed in the cytosol, it was successively detected in other cell types, such as 
human neutrophils, chondrocytes and hepatocytes. iNOS seems to be mainly implicated in 
cytotoxic actions of immune cells and inflammation  and its expression and activation are 
induced by cytokines [29, 30].  
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Figure 3: NO synthesis by the three NOS isozymes. (A) synthesis of NO by eNOS 
in endothelial cell stimulated by acetylcholine (ACh); (B) synthesis of NO by 
nNOS in a neuronal dendrite stimulated by glutamate (Glu); (C) expression of 
iNOS and synthesis of NO in a macrophage stimulated by cytokines. Adapted 
from [30].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It has been demonstrated that both the endothelial and the neuronal isoforms of NOS are 
calpain substrates [26, 27]. The limited digestion of nNOS is a conservative process without 
appreciable loss of catalytic activity of the synthase, whereas the degradation of eNOS occurs 
with a concomitant loss of protein and catalytic activity [27]. Also in this case HSP90 seems to 
play a crucial role in regulating the digestion of the two isozymes mediated by calpain. In basal 
conditions, HSP90 and NOS are associated in a heterocomplex in which the two substrates are 
almost completely resistant to calpain digestion, probably due to a structural steric hindrance 
[27]. Therefore the extent of NOS degradation depends on the level of HSP90 expression [27, 
28]. eNOS is much more vulnerable to calpain mediated digestion than nNOS. Indeed, HSP90 is 
more abundant in nervous tissue than in the endothelial tissue Particularly, in rat brain, which 
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contains a large excess of HSP90, nNOS is almost completely associated with this chaperone. 
Thus, following calpain activation, nNOS undergoes a limited proteolytic cleavage, even if it 
maintains its catalytic activity [28]. Instead, in aorta, which contains lower levels of HSP90, 
eNOS cannot undergo a complete association with the chaperone. In this condition, eNOS 
degradation result in the loss of synthase protein and consequently of catalytic activity [28]. The 
different ratios of HSP90/NOS displayed in the two tissue types seem responsible for the 
conservative or non-conservative digestion of NOS isozymes [26, 27].  
Specifically, in resting conditions the membrane-associated endothelial NOS is localized in 
caveolae, which are a specialized subset of lipid rafts widely present in the plasma membrane of 
endothelial cell. Interaction of eNOS with caveolae inhibits its synthase activity [32, 33]. eNOS 
can be directly activated by an increase in intracellular Ca
2+
, as well as by phosphorylation 
mediated by upstream kinases [32]. Once activated, eNOS dissociates from the plasma 
membrane and translocates to the cytosol. This removal from caveolae is an essential step 
required for the activation of the synthase and NO production [26]. However, eNOS is a highly 
sensitive calpain-1 substrate and the elevation of [Ca
2+
]i required for eNOS activation also leads 
to calpain-1 activation through its translocation to plasma membrane. Since eNOS degradation 
mediated by calpain is limited by the presence of HSP90 [26], the increase of Ca
2+
 concentration 
leads to the formation of a eNOS-HSP90 complex in which the synthase is protected from the 
proteolytic attack of activated calpain. On the other hand, cell treatment with a HSP90 inhibitor 
causes a massive eNOS degradation and suppression of NO production [26]. 
        
1.4 Membrane lipid rafts 
The plasma membrane regions defined caveolae are invaginations of 50-100 nm and can 
be a subcategory of lipid rafts enriched in cholesterol, glycosphingolipids, sphingomyelin and 
lipid-anchored membrane proteins [32]. Caveolae are present in several cell types, but 
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particularly abundant in endothelial cells [32 - 35]. One of the functional roles played by these 
specialized membrane regions consists in the regulation of some Ca
2+
-dependent signalling 
activities. In fact, several Ca
2+
-dependent enzymes, such as eNOS and its associated proteins are 
resident in caveolae [32, 33]. In the last decades, many information on endothelial cell responses  
to external stimuli have been acquired through the identification of signalling molecules able to 
interact with caveolae and responsible of modifications of the caveolae protein profile. The 
physical structure of lipid rafts is quite unique with a highly ordered liquid state that differs from 
the surrounding disordered phospholipid bilayer. This peculiar characteristic is mainly due to the 
enrichment of specialized lipids, which determine a distinct density of these microdomains with 
respect to the rest of the plasma membrane, and makes them resistant to solubilisation by non-
ionic detergents, such as Triton X-100 [35]. Such physical properties allow to isolate the 
membrane rafts from the rest of the cellular membranes, by applying several protocols, carried 
out using detergents or detergent free methods [35].  
One of the major structural protein in caveolae is caveolin-1, a 21-24 kDa integral 
membrane protein. Caveolin serves as the structural component of caveolae, while also functions 
as scaffolding protein, capable of recruiting several signalling molecules, as well as regulating 
their activity [33, 34]. The direct association of eNOS and caveolin-1 seems to regulate the 
synthase activity. In particular, in resting conditions, ceveolin-1 keeps eNOS sequestered in 
caveolae, inhibiting its catalytic activity. Thus, the synthase activation required the dissociation 
of the enzyme from caveolin-1 [26, 33].  
Membrane lipid rafts seems to function both as endocytotic/exocytotic carriers and as 
signal transduction organizing centres. In fact, they are involved in compartmentalization of 
several signal-transducing molecules in membrane microdomains [32, 33]. Moreover, 
experimental evidences have suggested the significant role played by lipid rafts in many 
biological processes, such as apoptosis, viral infections, cell adhesion and migration, synaptic 
transmission and organization of the cytoskeleton. Many of these physiological processes are 
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also known to require Ca
2+
 and thus it has been hypothesized that the lipid rafts can regulate 
these processes by modulation of Ca
2+ 
signalling [35] and regulation of intracellular Ca
2+
 
homeostasis. Specifically, the lipid rafts can regulate Ca
2+ 
signalling by a direct activation of 
Ca
2+
 channels, by operating signal transducers or by regulation of the trafficking of key proteins 
involved [35]. The link between lipid rafts and Ca
2+ 
signalling  is supported by the fact that 
caveolae are also enriched in molecules that regulate Ca
2+
 influx across membrane, such as IP3 
receptor-like, Ca
2+
-ATPase or members of the Transient Receptor Potential (TRP) family of 
capacitative Ca
2+
 entry (CCE) channels [35, 36]. Ca
2+
 is one of the simplest, yet perhaps the 
most versatile cellular messenger. It
 
is the major signalling ion in both excitable and non-
excitable cells, where it participates to a myriad of critical processes ranging from cell growth to 
cell death. Stimulation of cells by various endogenous agonists or pharmacological agents leads 
to either a Ca
2+
 influx across the plasma membrane or a release from intracellular stores. The 
latter phenomenon, in particular the release of Ca2+ from stores present in the Endoplasmic 
Reticulum (ER), can in turn activate a store-operated Ca
2+
 channel [35] that through Ca
2+
 influx 
from extracellular space also refill the ER stores. This mechanism, named Store-Operated Ca
2+ 
Entry (SOCE), involves some members of TRPC and Orai channels [35, 36]. Several studies 
indicate that key proteins implicated in Ca
2+
 signalling are localized in discrete plasma 
membrane lipid rafts microdomains and that caveolae are potential sites of extracellular Ca
2+ 
entry in response to ER Ca
2+ 
depletion [35, 36]. In fact, many of the regulators and channels, 
such as SOCE channels, involved in Ca
2+
 signalling have been found in lipid rafts. Clustering of 
Ca
2+
 channels and their modulators in such membrane microdomains can provide a spatial 
segregation and regulation of Ca
2+
-dependent events. Thus, membrane rafts represent a 
functional domain wherein as highly specific signalling events can be efficiently executed [35, 
36].  
In addition to Ca
2+
 channels and effectors of Ca
2+
 signalling, lipid rafts also 
compartmentalize many other signal transduction molecules and receptors which regulate 
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multiple cell functions [35, 37]. Epidermal Growth Factor (EGF) and Platelet-Derived Growth 
Factor receptors, muscarinic and α-, β-adrenergic receptors, serotonin and oxytocin receptors, 
MAP kinase, PKC, PLC and G proteins, among others, have been detected in lipid rafts 
microdomains [35, 37]. Since many signalling cascades and several physiological processes are 
associated to caveolae, it is conceivable that several diseases might be related to ablation or 
mutations of caveolin. Experiments performed in caveolin-deficient mice have demonstrated the 
functional significance of this protein in a variety of pathologies, including diabetes, cancer, 
cardiovascular diseases, pulmonary fibrosis and muscular dystrophies [34]. 
Since the plasma membranes are now considered dynamic interfaces also endowed of 
specialized microdomains favourable to the activity of membrane-associated proteins [38], both 
quantitative and qualitative variations in membrane lipid composition have been related to 
changes in the regulation of membrane protein functions. For example, Robinson et al have 
reported that the P2X7 purinergic receptor channel, associated with cholesterol-rich lipid rafts, is 
potentiated by depletion of cholesterol, suggesting that the influx through this nonselective 
cation channel can be regulated by changes in lipid rafts composition [39]. Furthermore, several 
alterations in brain lipid composition have been associated with both normal and pathological 
aging processes [38]. Overall these observations are consistent with the concepit that 
rearrangements in the composition of lipid rafts may play a crucial role in several functions 
played by these functional platform units of the cell membrane. 
 It has been shown that calpain-2 interacts with lipid rafts in human T-cell and cleaves its 
targets during Ag-specific T-cell signaling and immune synapse formation [40]. More recently 
active calpain-2 has been also identified in myotube caveolae where the protease processes 
vimentin, desmin and vinculin [41]. The possible localization and activation of calpain-1 at the 
lipid rafts has not yet been described. 
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2. AIM OF THE THESIS 
The aim of this thesis was to evaluate the possible presence of calpain-1 in membrane lipid 
rafts, to analyse the interaction/association of the protease with a few of its substrates and study 
the relevant function. Since lipid rafts are related to Ca
2+
 signalling [32 – 36], it is conceivable an 
involvement of these microdomains in activation of the Ca
2+
-dependent proteolytic system.  
Previous studies have indicated that dysregulation of Ca
2+
 homeostasis causes, in addition 
to an aberrant activation of the Ca
2+
-dependent proteolysis, an altered NO production [1, 11, 12]. 
These events occur in several pathologies, such as hypertension and diabetes and are related to 
endothelial dysfunction [11, 12].  
The relationship among calpain-1, NOS and the chaperone HSP90 and their association 
with lipid rafts have been analysed both in physiological conditions and following Ca
2+ 
stimulation, using a murine endothelial cell line. For this purpose, a protocol has been developed 
for the isolation of membrane lipid rafts, adapted from various papers in the literature. Then, it 
has been verified whether the lipid rafts microdomains undergo a protein reorganization 
following exposure to stimuli that increase the [Ca
2+
]i. Furthermore, through a cell viability assay 
it has been evaluated the role of calpain-1 and NOS in the endothelial cell. In support of the data 
obtained, some experiments have been carried out using animal models affected by Type 2 
diabetes and by obesity and insulin resistance. 
Furthermore, to establish if these membrane microdomains represent a specific site of 
activation and action of calpain-1 also in other cell types, the association of the protease with 
lipid rafts has been explored also in membranes isolated from a neuroblastoma cell line, where 
calpain-1 is associated to a NMDAR protein cluster. In order to obtain more information on the 
in vivo relationship between lipid rafts and alteration of Ca
2+
 homeostasis, an animal model 
characterized by a constitutive alteration of [Ca
2+
]i has been utilised. Particularly, we have 
utilised tissues obtained from normotensive and genetically hypertensive rats, analysing the 
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protein rearrangement of the lipid rafts that occurs in the pathological condition. These data have 
contributed to enhance our knowledge about the localization, role and function of calpain-1 
associated to these membrane domains, both in physiological conditions and in altered [Ca
2+
] 
conditions.  
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3. MATERIALS AND METHODS  
3.1 Reagents and antibodies 
Tween® 20, Triton® X-100, calpain inhibitor-1 (CI-1), calpain inhibitor-2 (CI-2), Ca
2+
-
ionophore A23187, Nω-Methyl-L-arginine acetate salt (L-NMMA), Neutral Red Solution 
(0.33%), mouse monoclonal anti-calpain-1 (calpain-1, subunit p80) clone 15C10, mouse 
monoclonal anti-calpain-2 (Domain III/IV) clone 107-82 and mouse monoclonal anti-
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibodies were purchased from Sigma-
Aldrich. ECL SELECT® Detection System and Protein G-Sepharose were obtained from GE-
Healthcare. Rabbit polyclonal anti-caveolin-1, mouse monoclonal anti-neuronal NO synthase 
(nNOS), anti-endothelial NO synthase (eNOS), anti-HSP90 and anti-NR2B antibodies were 
purchased from BD Transduction Laboratories. Mouse monoclonal anti-NR1 was obtained from 
Millipore. Rabbit polyclonal anti-EGFR was purchased from Santa Cruz Biotechnology. 
Monoclonal anti-calpastatin (Domain IV) clone 1F7E3D10 was bought from Calbiochem. 
Protease Inhibitor Cocktail (100X), Horseradish Peroxidase (HRP)-linked anti-mouse and HRP-
linked anti-rabbit secondary antibodies were purchased from Cell Signaling Technology. 
 
3.2 Animals 
For the experiments carried out in animals, 12-14 weeks old rats were used. For the first 
part of the study, rats (Charles River Laboratories, Wilmington, Massachusetts, USA) were 
divided into three groups: homozygote (fa/fa) male Zucker Diabetic Rats (ZDR), Zucker Fatty 
(obese) Rats (ZFR) and control heterozygote (fa/-) Zucker Lean Rats (ZLR). For the second part, 
rats (Rattus norvegicus Milan strain) were divided in 2 groups: normotensive and hypertensive 
rats. All the experimental procedures and animal care were conducted following the European 
Communities Council Directive of 24 November 1986 (86/609/EEC) and were approved by the 
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Italian Ministry of Health in accordance with Decreto Ministeriale 116/1992 (protocol number 
22698 of 17 September 2013). The related project dealt with the ethical and animal care aspects 
and was approved by the Committee set by the Ministry of Health at the National Institute of 
Health (Rome).  Rats were housed in controlled conditions of temperature (22±1°C), relative 
humidity (50%), and lighting (12 h a day), and were fed by a standard rat chow containing 0.3% 
sodium and drunk tap water ad libitum. Rats were anesthetized with sodium pentobarbital 
(Sigma Chemicals) and sacrificed by decapitation. Brain cortex and aorta were rapidly removed, 
quickly frozen in liquid nitrogen, and stored at -80 °C.  
 
3.3 Cell culture 
Murine endothelial bEnd5 cells and human neuroblastoma SK-N-BE cells were maintained 
in continuous culture at 37°C (5% CO2) with Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum, 10 U/mL penicillin, 100 mg/mL streptomycin and 2 
mM L-glutamine. All products used for cell culture were purchased from Euroclone S.p.A.  
 
3.4 Isolation of membrane lipid rafts  
For the isolation of membrane lipid rafts, a detergent-free method was developed and 
adapted from different protocols reported in Ref. [42 - 45]. All steps were carried out on ice. 
bEnd5 cells or SK-N-BE cells (35  106) were washed twice in phosphate-buffered saline (PBS), 
scraped from bottom of the flask and suspended in Tris 20 mM, pH 7.4, containing 250 mM 
sucrose (8.6% m/v), 1 mM CaCl2, 1 mM MgCl2, 19 µM calpain inhibitor-1 and Protease 
Inhibitor Cocktail (lysis buffer).  
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Alternatively rat brain cortex was suspended in 5 vol (w/v) of lysis buffer, minced and 
homogenized in a Potter Elvehjem homogenizer. The cells or the homogenized tissue were then 
lysed by passage through 22 g × 3” needle 20 times, as described in [43, 45]. For the elimination 
of nuclei, lysates were centrifuged at 1000× g for 10 min and the resulting postnuclear 
supernatant was collected, whereas the pellet was re-suspended in 1 mL of lysis buffer and again 
lysed by passage through needle as above. After a second centrifugation at 1000 g for 10 min, 
the second postnuclear supernatant was pooled with the first one and the pellet (nuclei) was 
discarded. Protein quantification of the samples collected was carried out using the Lowry 
method as described in [46]. Samples containing 3 mg of protein in 2 mL were then adjusted to 
45% sucrose by the addition of 2 mL of 90% sucrose in Tris 20 mM, pH 7.4, containing 0.15 M 
NaCl, and placed at the bottom of an ultracentrifuge tube. A discontinuous sucrose gradient was 
formed above by adding 4 mL of 30% sucrose and 4 mL of 5% sucrose as reported in [42]. 
Samples (total volume of 12 mL each) were subjected to ultracentrifugation for fractionation in a 
SW 28 rotor (Beckman) at 20,000 rpm for 18 h at 4°C in a SW28 rotor. This step allowed to 
separate different fractions depending on their density. From the top of each gradient, ten 
sequential fractions of 1.2 mL were collected, diluted in 3 mL of PBS and centrifuged at 
100,000× g for 40 min at 4°C. The pellets were suspended in Laemmli loading buffer [47], 
heated for 5 min at 95 °C and submitted to sodium dodecyl sulphate - polyacrylamide gel 
electrophoresis (SDS-PAGE) (15% for caveolin-1, 6% for the other proteins). 
 
3.5 Immunoblotting (Western Blot) 
For the immunoblot analysis of whole samples, aliquots of rat brain cortex and aorta were 
suspended in 5 vol (w/v) of ice-cold 50 mM sodium borate buffer, pH 7.5, containing 0.5 mM 2-
mercaptoethanol, 2 mM ethylenediaminetetracetic acid (EDTA) and Protease inhibitor Cocktail, 
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minced, homogenized in a Potter Elvehjem homogenizer and lysed by 3 cycles of sonication. 
Protein quantification of crude extracts obtained from the tissues considered above was assayed 
by the method of Lowry and aliquots of crude extracts were suspended in Laemmli loading 
buffer, heated for 5 min at 95 °C and submitted to 6% SDS-PAGE.  
Alternatively bEnd5 cells (3 × 10
6
), differently treated as described in Results, were 
washed twice in PBS and lysed in 500 µL of ice-cold 50 mM sodium borate buffer, pH 7.5, 
containing 1 mM EDTA and Protease Inhibitor Cocktail by sonication. In order to separate the 
total membrane fraction from cytosolic fraction, following protein quantification, cellular crude 
extracts were centrifuged at 100,000× g for 10 min at 4 °C and the supernatant (cytosolic 
fraction) was collected separately from the pellet (membrane fraction). Aliquots (30 µg) of crude 
extracts, cytosolic and total membrane fractions were suspended in Laemmli loading buffer, 
heated for 5 min  at 95 °C and submitted to SDS-PAGE (6%) and Western blot analysis. 
Fractions obtained from the isolation of membrane lipid rafts (as described above), after SDS-
PAGE, were also submitted to immunoblotting. 
Following electrophoresis, proteins were transferred to a nitrocellulose membrane (GE-
Healthcare) by electroblotting as reported by Towbin et al [48]. To detect the various proteins 
analysed, the nitrocellulose membranes were probed with the specific primary antibodies listed 
in the section Reagents and antibodies. The immunoreactive signal was developed using the ECL 
SELECT® detection system, detected with a Bio-Rad Chemi Doc XRS apparatus, and quantified 
using the Quantity One 4.6.1 software (Bio-Rad).  
 
3.6 Immunoprecipitation  
The fraction containing the highest amount of membrane lipid rafts obtained as described 
above was solubilized in 500 µL of 50 mM sodium borate buffer, pH 7.5, containing 1 mM 
EDTA and Protease Inhibitor Cocktail + 0.1% Triton X-100 (immunoprecipitation buffer) and 
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incubated at 37 °C for 1 h. The soluble proteins was precleared with protein G-Sepharose for 20 
min at room temperature (RT) and then incubated in the presence of the specific primary 
antibody at 4 °C, overnight. Protein G-Sepharose was then added to the sample and incubated for 
1 h at RT. The immunocomplexes were washed three times with immunoprecipitation buffer 
without Protease Inhibitor Cocktail and Triton X-100, suspended in Laemmli loading buffer and 
submitted to 6% SDS-PAGE followed by Western blot, as described above. 
 
3.7 Cell viability assay  
Cell viability was measured using the Neutral Red Uptake assay, as reported by Repetto et 
al [49]. Briefly, the neutral red uptake assay provides a quantitative estimation of the viable cells 
in a culture. It is based on the ability of viable cells to incorporate the neutral red dye in the 
lysosomes. Cells were seeded in 96-wells plates and treated for the appropriate period. The 
plates were then incubated for 2 h at 37 °C with a medium containing neutral red. The cells are 
then washed and the dye was extracted in each well with a destaining solution. The absorbance 
was finally read using a spectrophotometer set at a wavelength of 540 nm [49]. 
 
3.8 Statistical analysis  
Values are presented as means ± SEM. Significance of the differences was analysed by 
paired Student's t-test or ANOVA followed by post-hoc Tukey’s test, using the Prism 5.0 
GraphPad Software. The probability level taken to indicate significance was p < 0.05. 
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Figure 4: Distribution of eNOS in bEnd5 cells. Aliquots (30 µg) 
of cytosolic fraction (Cyt.) and total membranes (Mem.) from bEnd5 
cells obtained as described in Methods were subjected to SDS-
PAGE and immunoblot analysis was performed using anti-eNOS 
antibody. The protein is mostly present in the membranes fraction. 
The picture represents one of three different experiments performed.  
 
 
 
4. RESULTS  
4.1 Calpain-1, eNOS and HSP90 are present in a protein complex associated 
to lipid rafts/caveolin-1 membrane microdomains 
In the first part of this study, experiments were performed on bEnd5 cells, used as model of 
endothelial cell, in order to analyse the protein composition of lipid rafts/caveolin-1 membrane 
microdomains. First of all, by separation of total membranes fraction from cytosolic fraction, we 
verified the distribution of eNOS in bEnd5 cell. As previously reported [26, 32, 33], in resting 
conditions more than 95% of eNOS is associated with the membrane fraction (Fig. 4).  
 
                eNOS (130 kDa)  
 
 
 
 
 
 
 
bEnd5 cells lysate was fractionated on a discontinuous sucrose gradient by 
ultracentrifugation, in order to isolate lipid rafts microdomains, as described in Methods. 
Following fractionation, the protein concentrations of the fractions obtained were measured by 
the Lowry method (see Fig 5 A). For the identification of fractions containing lipid rafts, 
caveolin-1 was used as a marker, since it is particularly abundant in caveolae of endothelial cells 
[32 - 35]. After immunoblot analysis of the gradient fractions, most of eNOS was found in a 
single fraction (fraction 7), containing the marker caveolin-1, together with significant amounts 
of calpain-1 and HSP90. Both calpastatin and calpain-2 were not detectable in the various 
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Figure 5: Protein composition of lipid rafts/caveolin-1 membrane microdomains 
isolated from bEnd5 cells.  (A) bEnd5 cells (35 × 10
6
) were lysed to obtain lipid rafts as 
described in Methods. The protein concentration of each fraction was measured and only 
the values referred to fractions 3-9, containing detectable protein amounts, are reported. 
(B) Aliquots (30 µg) of each fraction obtained in (A) were subjected to immunoblot 
analysis with the indicated antibodies. The pictures represent one of the three experiments 
performed. The lipid rafts distribution does not exactly reflect the trend in protein 
concentration among the fractions. 
 
 
 
fractions, suggesting a selective association of calpain-1 with these membrane regions, in which 
its natural inhibitor is absent (Fig 5 B).  
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Figure 6: Immunoprecipitation of eNOS associated to lipid rafts. Aliquots 
(500 µg) of soluble proteins (Total) obtained from fraction 7 were 
immunoprecipitated using 2 µg of anti-eNOS antibody as described in Methods. 
30 µg of Total and all the immunoprecipitated material (IP) were submitted to 
Western blot using the indicated antibodies. The picture represents one of three 
experiments performed. 
 
 
 
To verify if these proteins are physically associated, immunoprecipitation was performed 
on fraction 7, containing the most abundant amount of eNOS and caveolin-1. As shown in Fig. 
6, using anti-eNOS antibody to perform the immunoprecipitation, we demonstrated that eNOS, 
calpain-1 and HSP90 are present in a single protein complex also associated with caveolin-1,.  
 
 
 
 
 
 
 
4.2 Ca
2+
-dependent protein modifications in caveolae  
As already mentioned in Introduction, in endothelial cells the lipid rafts/caveolae 
represent platforms in the plasma membrane where Ca
2+
 signalling is locally regulated to 
induce specific cell responses [35]. It is conceivable that lipid rafts are involved also in 
regulating Ca
2+
 influx required for the activation of both eNOS and calpain-1 and that the 
chaperone HSP90 controls calpain-1 activation in these microdomains. Thus, the 
eNOS/calpain-1/HSP90 complex associated to caveolae could be used as a model to study the 
protein changes mediated by perturbations of Ca
2+
 homeostasis. As demonstrated by several 
reports [50 – 55], one of the conditions that induces alterations in [Ca2+]i is the cell exposure to 
high glucose levels, as it occurs in diabetes mellitus. In endothelial cells, high glucose 
condition promotes dysregulation of Ca
2+
 homeostasis that leads to activation of Ca
2+
-
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Figure 7: Modifications of eNOS, calpain-1 and HSP90 levels in lipid raft/caveolin-1 
membrane microdomains following HG treatment. bEnd5 cells (35 × 10
6
), cultured for 
48 h in DMEM (C) or in DMEM + 25 mM glucose (HG), were lysed to isolate lipid rafts. 
Aliquots (30 µg) of gradient fraction 7 were subjected to immunoblotting with the 
indicated antibodies.. The immunoreactive material was detected and quantified. The 
reported values are means ± SEM of five independent experiments performed. The 
pictures represent one of the five experiments carried out. 
 
 
dependent systems, such as the Ca
2+
-dependent proteolysis [50 - 55]. In fact, it has been 
demonstrated that the endothelial dysfunction, a recurrent complication of diabetes, is also 
characterized by an aberrant activation of calpain [50, 53, 55]. 
Thus, in order to simulate a pathological condition, bEnd5 cells have been exposed to 25 
mM glucose for 48 h (High Glucose, HG) (normally the glucose concentration in the cell 
culture medium is about 5 mM, which reflects the in vivo physiological concentration). 
Alternatively cells have been treated with 1 µM Ca
2+
-ionophore (A23187) for 30 min, causing 
a significant increase in intracellular Ca
2+
 levels. Following treatments, lipid rafts/caveolin-1 
membrane microdomains were isolated and the levels of eNOS, calpain-1 and HSP90 present 
in fraction 7, obtained from sucrose gradient as described above, were revealed by Western 
blot. As shown in Fig. 7, exposure to HG led to a 60% decrease in eNOS level as compared to 
control cells (C). The calpain-1 level was not changed significantly. Unexpectedly, the amount 
of HSP90 was approximately 2-fold increased.  
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Interestingly, as shown in Fig. 8, treatment with Ca
2+
-ionophore led to very similar 
results. These data suggest that both events are directly associated with the increase in [Ca
2+
]i.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3 eNOS digestion is mediated by lipid rafts-associated calpain-1  
The reduction in eNOS levels associated to lipid rafts/caveolin-1 membrane 
microdomains, following the treatment with either HG or Ca
2+
-ionophore, could be explained 
through two concomitant events. As indicated by several reports [26, 27, 33] and already 
mentioned in Introduction, the Ca
2+
-dependent activation of eNOS involves the dissociation of 
Figure 8: Modifications of eNOS, calpain-1 and HSP90 levels in lipid 
raft/caveolin-1 membrane microdomains following Ca
2+
-ionophore treatment. 
bEnd5 cells (35x10
6
), left untreated for 30 min in DMEM (C) or treated for 30 min 
with 1 µM Ca
2+
-ionophore A23187 (I), were lysed to isolate lipid rafts. Aliquots 
(30 µg) of gradient fraction 7 were subjected to immunoblotting with the indicated 
antibodies.. The immunoreactive material was detected and quantified. The 
reported values are means ± SEM of five independent experiments performed. The 
pictures represent one of the five experiments carried out. 
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Figure 9 A: Calpain-mediated digestion of eNOS following HG treatment. 
bEnd5 cells (3 × 10
6
) cultured for 48 h in DMEM (Ctrl), or in DMEM + 25 mM 
glucose (HG), or in DMEM + 25 mM glucose in the presence of 2 µM CI-2 (HG+CI-
2) were lysed as described in Methods and aliquots (30 µg) of crude extracts were 
submitted to SDS-PAGE followed by immunoblotting and probed with the indicated 
antibodies. The immunoreactive bands were quantified. The reported values are 
means ± SEM of five independent experiments performed. eNOS quantification was 
normalized versus GAPDH immunoreactive band intensity, used as loading control 
protein. * significantly different as compared to controls (p = 0.0417); **p = 0.0204. 
The picture represents one of the five experiments carried out. 
 
 
 
the synthase from the caveolae and its translocation to cytosol. But, at the same time, under 
increased [Ca
2+
]i conditions, the active calpain-1 digests its substrates, including eNOS.  
To better characterize this process, bEnd5 cells have been treated with HG or Ca
2+
-
ionophore in the absence or in the presence of a cell permeable calpain inhibitor (CI-2) and 
total amount of eNOS was then evaluated. As shown in Fig. 9 A and B, the decrease in eNOS 
level, induced by HG or Ca
2+
-ionophore treatments, was prevented by the presence of CI-2. 
Although CI-2 does not specifically inhibits calpains-1, it has previously been demonstrated 
that calpain-1 is involved in the degradation of eNOS, while calpain-2 regulates eNOS 
phosphorylation in endothelial cell [56]. Thus, we could confirm that eNOS digestion is 
mediated by calpain-1.   
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Figure 9 B: Calpain-mediated digestion of eNOS following Ca
2+
-ionophore 
treatment. bEnd5 cells (3 × 10
6
) left untreated for 30 min in DMEM (Ctrl), treated for 
30 min with 1 µM Ca
2+
-ionophore A23187 (Ca
2+
) or incubated with 1 µM CI-2 for 30 
min, followed by an incubation with 1 µM Ca
2+
-ionophore A23187 for 30 min 
(Ca
2+
+CI-2) were lysed as described in Methods and aliquots (30 µg) of crude extracts 
were submitted to SDS-PAGE followed by immunoblotting and probed with the 
indicated antibodies. The immunoreactive bands were quantified. The reported values 
are means ± SEM of five independent experiments performed. eNOS quantification 
was normalized versus GAPDH immunoreactive band intensity, used as loading 
control protein. * significantly different as compared to controls (p = 0.0145); **p = 
0.0403. The pictures represent one of the five experiments carried out. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
However, the decrease of eNOS observed in lipid rafts/caveolin-1 membrane 
microdomains, and reported in Fig 7 and Fig. 8, is more pronounced than that detected in total 
cell (Fig. 9 A and B). This discrepancy was explained by the fact that, following [Ca
2+
]i increase, 
an aliquot of eNOS was dissociated from the plasma membrane as an active enzyme form and 
translocated to the cytosol. The amounts (expressed as %) of eNOS dissociated from lipid rafts 
or digested by calpain-1, following HG or Ca
2+
-ionophore treatments, are reported in Table 1.  
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Table 1: Digestion of eNOS and its release from lipid rafts.  
All data are presented as the arithmetical mean ± SE. 
(a) 100% is the level of eNOS measured in untreated cells. 
(b) Values were extrapolated from Fig. 9 A and 9 B. 
(c) Values were extrapolated from Fig. 7 and Fig. 8. 
(d) Values were extrapolated subtracting the level of eNOS in lipid 
rafts (c) from that in total cells (b) measured following the same cell 
treatment. 
(e) Values are the differences between the level of eNOS obtained from 
total untreated and treated cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to verify if calpain-1 resident in caveolae was the isoform responsible for this 
eNOS digestion, the gradient fraction containing lipid rafts/caveolin-1 microdomains (fraction 
7), obtained from untreated bEnd5 cells, was incubated with a [Ca
2+
] sufficient to fully activate 
lipid rafts-associated calpain-1 in vitro. As shown in Fig. 10, following the treatment, a 70% 
eNOS reduction was detected and, in this case, also HSP90 decreased, although at a lower extent 
(40 – 45%). These results demonstrated that resident calpain-1 is involved in eNOS digestion. 
The activation and expression of catalytic activity of resident calpain-1 is also promoted by the 
absence of its natural inhibitor calpastatin in caveolae (as shown in Fig. 5). As mentioned in 
Introduction and reported in [26], HSP90 is also a calpain-1 substrate and this explains the 
HSP90 reduction detected in isolated lipid rafts following exposure to Ca
2+
. However, HSP90 is 
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also involved in regulating calpain-1 activity increasing the Ca
2+
 request for the protease 
activation [24]. Therefore, increase of lipid rafts-associated HSP90 observed in Fig. 7 and Fig. 8, 
following treatment with HG or Ca
2+
-ionophore, could be visualized as an attempt to reduce the 
calpain-1 activation and thus the digestion of its targets in these membrane structures, through 
the chaperone recruitment from cytosol. The Fig. 11 shows the proposed model for the lipid rafts 
modification following the increase in [Ca
2+
]i.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Calpain-mediated digestion of eNOS and HSP90 in isolated lipid 
raft/caveolin-1 membrane microdomains. (A) Gradient fraction 7 obtained as 
described in Methods was suspended in 120 µl of 50 mM sodium borate, pH 7.5 
containing 1 mM EDTA and 0.5 mM 2-mercaptoethanol. Aliquots (50 µl) of the 
sample were incubated at 37 °C for 60 min in the presence (Ca
2+
) or absence (C) of 
1 mM Ca
2+
 and then were submitted to SDS-PAGE, followed by immunoblotting. 
eNOS and HSP90 were detected using the specific antibodies. The pictures 
represent one of the five experiments performed. (B) The immunoreactive bands 
detected were quantified. The reported values are means ± SEM of five 
independent experiments performed. * significantly different as compared to 
controls (p = 0.0035); # significantly different as compared to controls (p = 
0.0057). 
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4.4 Calpain-1 plays a protective role in endothelial cell 
As reported so far, alteration of Ca
2+
 homeostasis leads to an alteration of the protein 
composition of caveolin-1 microdomain and of its function. It is conceivable that the protein 
rearrangement, occurring in lipid rafts, could represent a protective mechanism against Ca
2+
-
induced cell damages. However, although calpain-1 has been related to several pathological 
conditions, some reports have suggested that calpain-1 activity is involved in cell protection, 
especially against neurodegeneration [57, 58]. To investigate the role of calpain-1 in 
endothelial cell, the viability of bEnd5 cells was assayed, following appropriate treatments. 
bEnd5 cells, left untreated or treated with HG for 48 h, were exposed to 1 µM Ca
2+
-ionophore 
for 2 h to cause 50 – 60% cell death. As shown in Fig. 12, cell death was reduced in cells 
previously treated with HG, suggesting that the calpain-1 activation, induced by exposure to 
HG, could have a positive effect. This hypothesis was supported by an increment in cell death 
when bEnd5 cells were treated with Ca
2+
-ionophore, following exposure to HG in the presence 
Figure 11: Proposed model for the protein reorganization of the lipid raft. (A) In 
resting cells, calpain-1 (Calp-1) is associated in an inactive form to membrane 
microdomains containing caveolin-1 (Cav-1), together with eNOS and HSP90. (B) In Ca
2+
 
loaded cells, eNOS becomes active, dissociates from caveolae and translocates to cytosol, 
producing NO. Also calpain-1 becomes active and an intense or prolonged activation of 
the protease leads to the digestion of both eNOS and HSP90. However, in order to 
counteract the abnormal activation of calpain-1 and degradation of eNOS, HSP90 is 
recruited from cytosol. 
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of CI-2 for 48 h, indicating that the calpain-1 inhibition increases cell damages, whereas its 
activation and the consequent controlled digestion of eNOS limit such damages. This fact was 
confirmed by a decrease in cell death when Ca
2+
-ionophore exposure was carried out in the 
presence of a synthetic inhibitor of NOS, L-NMMA. However, cell death was also reduced if 
CI-2 was added only during the 2 h of Ca
2+
-ionophore treatment. These results suggest that 
both the aberrant activation of calpain-1 and the over-activation of eNOS are responsible for 
endothelial cell damage. The first event can lead to a depletion of HSP90, whereas the second 
one promotes the over-production of NO and the possible consequent accumulation of ROS. 
 
    
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Cell viability of bEnd5 cells in different conditions of intracellular 
Ca
2+
 overloading. bEnd5 cells (10
4
) incubated for 48 h in DMEM + 25 mM glucose 
in the presence of 2 µM CI-2 [HG+CI-2 (48 h)] were treated for 2 h with 1 µM Ca
2+
-
ionophore A23187. bEnd5 cells (10
4
) incubated for 48 h in DMEM + 25 mM glucose 
were treated for 2 h with 1 µM Ca
2+
-ionophore A23187 alone (HG), or in the presence 
of 2 µM CI-2 [HG+CI-2 (2 h)], or in the presence of 1 mM L-NMMA (HG+NMMA). 
As control (C), bEnd5 cells (10
4
) were incubated for 48 h in DMEM and then treated 
for 2 h with 1 µM Ca
2+
-ionophore A23187. After all incubations cell viability was 
evaluated by Neutral Red Uptake assay (see Methods). The values reported are the 
arithmetical mean ± SEM of six independent experiments performed. * significantly 
different as compared to controls (p < 0.001) according to ANOVA followed by post-
hoc Dunnett's test; ** p = 0.0005 [HG vs HG+CI-2(48h)] according to t-test. 
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4.5 Alterations of the Ca
2+
-proteolytic system in diabetic rat aorta  
To assess whether the processes so far detected in an endothelial cell line occur also in 
vivo, the levels of calpain-1, eNOS and HSP90 were evaluated in aorta and brain cortex of 
ZDR, ZFR and ZLR animal models (see Materials and Methods). Rats tissues were processed 
and total lysates were submitted to immunoblotting, as reported in Methods. As shown in Fig. 
13, in aorta of diabetic rats (ZDR), characterized by a significantly higher blood plasma glucose 
levels, the amounts of calpain-1, eNOS and HSP90 were considerably reduced as compared to 
lean rats (ZLR), used as controls, whereas in aorta of obese rats (ZFR), characterized by 
hyperinsulinemia and higher systolic arterial pressure, were poorly affected. These data suggest 
that in aorta of hyperglycaemic rats an intense calpain-1 activation occurs, resembling the 
digestion of lipid rafts proteins observed in endothelial cells following exposure to HG or Ca
2+
-
ionophore. 
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Figure 13: Calpain-1, eNOS and HSP90 protein level in aorta of ZLR, ZFR, and 
ZDR. (A) 50 µg or (B) 25 µg of proteins of crude extracts, prepared as described in 
Methods from aorta of ZLR, ZFR, and ZDR were submitted to SDS-PAGE and  
immunoblotting. (A) calpain-1, (B) eNOS (light grey bars) and HSP90 (dark grey bars) 
were detected using the specific mAbs. The immunoreactive material was developed 
and quantified. The images represent one of the experiments carried out. The reported 
values are means ± SEM of five independent experiments performed. Protein 
quantification was normalized versus the GAPDH immunoreactive band intensity, used 
as the loading control protein. (A) * significantly different as compared to ZLR (p = 
0.0469); **p = 0.0019 (ZFR vs ZDR); *** significantly different as compared to ZLR 
(p < 0.0001). (B) * significantly different as compared to ZLR (p = 0.0489); **p = 
0.0206 (ZFR vs ZDR); *** significantly different as compared to ZLR (p = 0.0061); # 
significantly different as compared to ZLR (p = 0.0494); ##p < 0.0001 (ZFR vs ZDR); 
### significantly different as compared to ZLR (p = 0.0003).  
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Figure 14: Calpain-1, nNOS and HSP90 protein level in brain cortex of ZLR, ZFR, 
and ZDR. (A) 50 µg or (B) 25 µg of proteins of crude extracts, prepared as described in 
Methods from brain cortex of ZLR, ZFR, and ZDR were submitted to SDS-PAGE and  
immunoblotting. (A) calpain-1, (B) nNOS (light grey bars) and HSP90 (dark grey bars) 
were detected using the specific mAbs. The immunoreactive material was developed 
and quantified. The images represent one of the experiments carried out. The reported 
values are means ± SEM of five independent experiments performed. Protein 
quantification was normalized versus the GAPDH immunoreactive band intensity, used 
as the loading control protein. (B) * significantly different as compared to ZLR (p < 
0.0001); **p < 0.0134 (ZFR vs ZDR).  
 
 
 
 
 
In order to verify if these alterations induced by hyperglycaemia affect also other tissues, 
the amounts of calpain-1, HSP90 and the neuronal isoform of NOS, nNOS, were measured in 
brain cortex from ZDR, ZFR and ZLR. As reported in Fig. 14, the levels of calpain-1 and 
HSP90 in both diabetic and obese animals were comparable to that detected in lean control rats, 
whereas nNOS was slightly increased in ZDR. These results suggest that, although nNOS is a 
calpain-1 substrate, the fluctuations in Ca
2+
 homeostasis induced by hyperglycaemia and the 
consequent proteins alterations are tissue specific.  
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4.6 Calpain-1, inserted into multiprotein NMDAR complex, is associated to 
lipid rafts in SK-N-BE cells 
As previously reported, calpain-1 is associated to the NMDAR multiprotein complex, 
together with HSP90 in resting SK-N-BE neuroblastoma cells [22]. As in bEnd5 cells, also in 
SK-N-BE cells calpain-2 and calpastatin are not detectable at this protein complex (see Fig. 
15).    
 
    
 
 
 
 
  
 
 
Several studies have suggested that in nervous tissues NMDAR is associated to lipid rafts 
and this interaction can be modified during memory formation or by chemical agents [59 – 61]. 
However, there is very limited information about the possible association of calpain-1 and some 
of its substrates to membrane lipid rafts in cells of the nervous system. Thus, we evaluated if this 
association, already detected in endothelial cells, was present also in neuroblastoma cells, 
commonly used as an in vitro model in neurobiology [62]. Although caveolin-1, abundant in 
Figure 15: Immunoprecipitation of the NR1 subunit in SK-N-BE 
cells. The NR2B subunit, detectable as a 180 kDa native form and a 
60 kDa digested form, HSP90 and calpain-1 are co-
immunoprecipitated with the NR1 subunit. Adapted from [22]. 
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Figure 16: Protein composition of lipid rafts isolated from SK-N-BE 
cells.  (A) SK-N-BE cells (35 × 10
6
) were lysed to obtain lipid rafts as 
described in Methods. The protein concentration of each fraction was 
measured and only the values referred to fractions 3-9, containing measurable 
protein level, are reported. (B) Aliquots (30 µg) of each fraction were 
subjected to immunoblot analysis with the indicated antibodies. The pictures 
represent one of the three experiments performed.  
 
 
 
endothelium, has been found in blood-brain barrier [63], it is not equally expressed in nervous 
tissues, where it is poorly detectable (see Fig. 17 B and 18 B). Thus, EGFR, typically associated 
to membrane lipid rafts and particularly expressed in cells of nervous system, was chosen as 
marker of lipid rafts [35, 64]. Membrane lipid rafts were isolated from SK-N-BE cells following 
the same protocol used for bEnd5 cells and protein concentration was measured in each gradient 
fraction by the Lowry method  (Fig. 16 A). After immunoblot analysis, the lipid rafts marker 
EGFR was recovered predominantly in the fraction 7, the same gradient fraction in which we 
previously detected caveolin-1 in bEnd-5 cells. In the same fraction we also recovered 
significant amounts of calpain-1, NMDAR subunits (NR1 and NR2B), HSP90 and the neuronal 
isoform of NOS (nNOS), whereas calpain-2 was not detectable in any fraction (Fig. 16 B). 
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4.7 Alteration in Ca
2+
 homeostasis modifies the protein composition of lipid 
rafts isolated from rat brain cortex  
To obtain more information on the relationship between the lipid rafts structure and Ca
2+ 
homeostasis and to study the possible lipid rafts reorganization caused by fluctuations in [Ca
2+
] 
in nervous tissue, we utilised, as an animal model, genetically hypertensive rats from the Milan 
strain, characterized by a constitutive alteration in [Ca
2+
]i [65 – 67]. Particularly, we analysed 
the protein composition of lipid rafts isolated from brain cortex of normotensive and 
hypertensive rats from the same strain.  
After the collection of the ten gradient fractions, protein concentration was measured and 
the values obtained from normotensive rats (see Fig. 17 A) showed a distribution similar to that 
measured in SK-N-BE cells. However, as shown in Fig. 17 B, the marker EGFR was found 
mainly among the fractions 5 and 7, also containing significant amounts of nNOS, whereas 
calpain-1, NMDAR subunits and HSP90 were recovered predominantly between fractions 6 
and 7. As already mentioned, caveolin-1 was very poorly detectable, so it could not be used as 
a reliable lipid rafts marker in nervous tissue. Calpain-2 was not detectable, confirming the high 
degree of selectivity of the calpain-1 isoform in these membrane structures.  
To verify if a chronic alteration in Ca
2+
 homeostasis could cause modifications and 
reorganization in lipid rafts, we isolated these membrane microdomains from brain cortex of  
hypertensive rats. Surprisingly, preliminary results highlighted that the distribution of lipid rafts 
and of the proteins of our interest among the fractions was profoundly different than that 
observed in normotensive animals (see Fig. 18 B). The marker EGFR was accumulated in 
lower density gradient fractions ( fractions 3 and 4), where calpain-1 and HSP90 were absent. 
The levels and the localization of calpain-1 were not significantly affected in hypertensive 
animals, whereas HSP90 disappeared in fraction 7 and underwent a shift to fractions 8 and 9, 
although at lower amounts. NR1, NR2B and nNOS were distributed both in the lowest and 
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Figure 17: Protein composition of lipid rafts isolated from 
normotensive rat brain cortex.  (A) Brain cortex samples were lysed 
to obtain lipid rafts as described in Methods. The protein concentration 
of each fraction obtained was measured and only the values referred to 
fractions 3-9, containing detectable protein amounts, are reported. (B) 
Aliquots (30 µg) of each fraction were subjected to immunoblot analysis 
with the indicated antibodies. The pictures represent one of the three 
experiments performed.  
 
 
 
highest density fractions, but the total amounts of NR2B and nNOS, both calpain-1 substrates 
[22, 23, 27], were slightly decreased. It is interesting to note that also the protein concentration 
of the various fractions was significantly different from those obtained from normotensive 
animals (see Fig. 17 A and 18 A). 
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Figure 18: Protein composition of lipid rafts isolated from 
hypertensive rat brain cortex.  (A) Brain cortex samples were lysed to 
obtain lipid rafts as described in Methods. The protein concentration of 
each fraction obtained was measured and only the values referred to 
fractions 3-9, containing detectable protein amounts, are reported. (B) 
Aliquots (30 µg) of each fraction were subjected to immunoblot analysis 
with the indicated antibodies. The pictures represent one of the three 
experiments performed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To investigate if the protease resident in these membrane structures was responsible for 
digestion of its substrate also in nervous tissue, the gradient fraction containing the highest 
amount of both EGFR and calpain-1 (fraction 7), obtained from normotensive rat brain, was 
incubated with Ca
2+
 in order to activate the protease. As shown in Fig. 19, calpain-1 was 
slightly decreased (approximately 20%) by auto-proteolysis, whereas HSP90, one of calpain-1 
substrates present in the same gradient fraction, was approximately 70% reduced. As expected, 
calpain-1 and HSP90 decrease was almost completely prevented if the treatment with Ca
2+
 was 
performed in the presence of the calpain-inhibitor-2, confirming that HSP90 reduction was due 
to a selective digestion mediated by calpain-1. Although further analyses are necessary to 
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hypothesize a possible role of calpain-1 in lipid rafts of rat brain cortex, altogether these 
preliminary results suggest that following activation of calpain-1 resident at the lipid raft, the 
digestion of proteins associated to these structures and their redistribution can be required for 
triggering the onset or sustain specific cell functions or can represent a mechanism for cell 
adaptation to the increase in [Ca
2+
]i.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Calpain-mediated digestion of HSP90 in isolated lipid rafts from 
normotensive rat brain. Gradient fraction 7 obtained from brain cortex samples 
as described in Methods,  was suspended in 150 µl of 50 mM sodium borate, pH 
7.5 containing 1 mM EDTA and 0.5 mM 2-mercaptoethanol. Aliquots (50 µl) of 
the sample were incubated at 37 °C for 60 min in absence (Ctrl) or in presence 
(+Ca
2+
) of 1 mM Ca
2+
 or, alternatively,  in presence of 1 mM Ca
2+ 
and 2 µM CI-2 
(+Ca
2+
+CI-2) and then were submitted to SDS-PAGE, followed by 
immunoblotting. Calpain-1 (dark grey bars) and HSP90 (light grey bars) were 
detected by using the specific primary antibodies and the immunoreactive bands 
were quantified. The pictures represent one of the three experiments performed. 
The reported values are means ± SEM of three independent experiments 
performed. * significantly different as compared to controls (p < 0.05); ** 
significantly different as compared to (+Ca
2+
) (p < 0.05). 
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5. DISCUSSION                                                    
 It has been reported that calpain-1, once intracellularly activated by a mobilization of 
calcium ions, translocates from the cytosol to the plasma membrane, where it may catalyse the 
limited digestion of its substrates, which predominantly consist of plasma membrane-associated 
proteins. [11, 13]. However this model seems insufficient to explain the selectivity of calpain-
mediated digestion, since the protease does not have a specific consensus sequence [2, 68]. Here 
we have addressed our research starting from previous observations, obtained from us and from 
other Authors, that identified an aliquot of calpain-1 associated with the plasma membrane in 
resting cells [11, 26]. Thus, focusing on this calpain-1 localization, we have analysed if a 
selective interaction of the protease with a pool of specific proteins could contribute to regulate 
its catalytic activity and the molecular features responsible of its autocatalytic activation and sub-
cellular localizations in resting and altered conditions of intracellular Ca
2+ 
homeostasis.  
It is important to note that we have isolated membrane lipid rafts following a new protocol, 
adapting different procedures carried out with both cells and ex vivo tissues. The insolubility of 
these membrane microdomains, rich in cholesterol and sphingolipids, in non-ionic detergents, 
such as Triton-X 100, has been previously widely exploited for their isolation. However, it has 
not been fully established that all rafts are detergent resistant. Moreover it has been shown that 
many detergent resistant membrane fractions unrelated to rafts can be obtained [69]. Particularly, 
the use of detergent can produce artifacts or interfere with glycolipids distribution in brain 
tissues [45]. Several lipid rafts-associated proteins, many of which have remained undetected for 
a long time [44], have been now identified by proteomics studies. However, interpretation of 
individual studies is limited by potential undefined contaminant proteins [70]. For these reasons, 
in the last two decades the protocols for the isolation of rafts have been directed toward the use 
of detergent-free methods, taking advantage of the unique buoyant density of membrane rafts 
[44]. Persaud-Sawin et al [45] reported an optimized detergent-free method for lipid rafts 
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isolation from brain tissue, compared to Triton-X 100-based method. It has been shown that the 
best yield is obtained in the absence of detergent. For our work, we developed a detergent-free 
protocol suitable for both cell lines and tissues, exploiting the typical density of lipid rafts. In 
future experiments, other lipid rafts markers might be used in addition to those that we have so 
far selected, to verify a possible overlap or divergence with other similar membrane structures.   
Our results demonstrate that in endothelial and neuroblastoma cell lines as well as in rat 
brain cortex, lipid rafts membrane microdomains are the site of activation and action of calpain-1 
associated with the plasma membrane. In the same localization we also detected NOS and 
HSP90. Moreover, in SK-N-BE cells and rat brain, these enzymes also interact with the 
NMDAR protein cluster. Although calpain-1 and calpain-2 share many protein targets of their 
proteolytic attack [11], the different roles played by the two proteases could be explained not 
only in the basis of the different Ca
2+
 requirement necessary for their activation in vitro, but also 
by a distinct cellular localization that promotes a peculiar accessibility to their relevant 
substrates. The results obtained in the present study are consistent with previous observations 
that attributed a different role to calpain-1 and calpain-2 towards single intracellular putative 
substrates. Specifically, the alternative silencing of both calpain-1 and calpain-2 isozymes in 
endothelial cells has  demonstrated that degradation of eNOS depends only on calpain-1 activity, 
while calpain-2 regulates eNOS, promoting its phosphorylation [56]. Moreover, it has been 
shown very recently that calpain-1 deficient mice experienced reduced leukocyte adhesion to the 
aortic endothelium in response to myeloperoxidase, establishing a role for calpain-1, but not for 
calpain-2, in the endothelial dysfunction and vascular inflammation [71]. Conversely, 
VEGF/VEGFR2 induces calpain-2 dependent activation of PI3K/AMPK/Akt/eNOS pathway in 
endothelial cells and consequently the production of NO and a physiological angiogenesis [72]. 
In our experimental conditions, the absence of calpain-2 in the lipid rafts membrane 
microdomains makes the substrates accessible only to calpain-1. 
53 
 
The data obtained in bEnd5 cells indicate that a controlled but significant degradation of 
eNOS operated by calpain-1 is crucial to maintain proper amounts of active eNOS, preventing 
the accumulation of NO and the generation of Reactive Oxygen Species (ROS) which could 
damage cell structures [31]. The digestibility of eNOS and the extent of activation of calpain-1 
are on the other hand modulated by HSP90 [24, 27, 28]. When the three proteins are located in 
the same cell structure and associated each other, eNOS digestion is strictly controlled. Indeed, 
the increase in the levels of HSP90 in the lipid rafts, following a stimulation with Ca
2+
, can be 
interpreted as a mechanism for regulating the process of both autolytic calpain-1 activation and 
efficiency of its proteolytic activity towards the co-localized susceptible substrates. It is 
important to consider that, through this mechanism, calpain-1 can undergo regulation also in 
absence of its specific calpastatin inhibitor. As a result of the chaperone accumulation and 
protein reorganization in caveolin-1 microdomains, bEnd5 cells  exposed to HG acquire a major 
resistance to Ca
2+
-mediated insult, as revealed by cell viability assays. Cell viability probably 
depends on a balance between activation of calpain-1 and eNOS. An imbalance of these two 
events seems to shift the cell from a defensive or adaptive condition to an amplified and 
irreversible damaging conditions that leads to cell death. In this context, calpain-1 could play a 
protective role against NO overproduction, limiting the amount of eNOS protein.  
Through the experiments performed in aortic endothelium of diabetic rats, it has been 
possible to prove that a prolonged perturbation of intracellular Ca
2+
 homeostasis can promote the 
transition from a cell defensive physiological condition to a pathological one. In aorta of diabetic 
rats, calpain-1, eNOS and HSP90 levels are significantly reduced compared to control animals 
and the alteration in the protein complex probably affects the interaction among the three 
proteins, causing a deficient control of the production of NO, necessary to preserve the 
endothelium functionality. Since in brain cortex of diabetic rats the three proteins remain 
completely unaffected, we can conclude that the alterations induced by hyperglycaemia are 
tissue speciﬁc. In fatty rat aorta, the levels of the three proteins are only slightly reduced, 
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indicating that in these animals the protein complex is poorly altered and calpain-1, eNOS and 
HSP90 are still operating in order to counteract the onset of endothelial dysfunctions.  
The lipid rafts represent a specific site of activation of calpain-1 also in neuroblastoma 
cells and in nervous tissue, where the protease is selectively inserted in the NMDAR protein 
complex [22] and associated to lipid rafts/EGFR membrane microdomains also containing 
nNOS. Also this localization seems highly specific since calpain-2 is not detectable. In these 
regions of the plasma membrane, calpain-1 is involved in modulating the levels of both the 
glutamate receptor and nNOS, in order to control a toxic Ca
2+
 inﬂux or an excessive NO 
production, due to a possible over-activation of these two proteins involved in Ca
2+
 mediated 
events [22, 23, 27]. In fact, it has been observed that digestion of the NR2B subunit and nNOS 
are strictly related to cell function and survival. Specifically, once digested, NR2B is rapidly 
internalized in inner membranes, preventing a damaging influx of Ca
2+
 [22].  
In normotensive rat brain cortex, calpain-1 shows a distribution among the gradient 
fractions, obtained for the isolation of lipid rafts, similar to that observed in SK-N-BE cells. The 
partioning in lipid rafts probably improves the selectivity of calpain-mediated proteolysis 
towards its susceptible protein targets, preventing an aberrant and widespread action of the 
protease that could cause cell damages. The changes detected in the levels and in the gradient 
fractions distribution of the proteins analysed in brain cortex of genetically hypertensive rats 
suggest that when the protease is activated by a prolonged increase in [Ca
2+
]i, as it occurs in the 
tissues of these animals, the digestion of the chaperone HSP90 promotes a considerable lipid 
rafts reorganization, which probably allows a cell adaptation to the alteration of Ca
2+
 
homeostasis, preventing an excessive calpain-1 activation. The results obtained from in vitro 
experiments on isolated lipid rafts, in which the resident calpain-1 is in situ activated by Ca
2+
 
loading, demonstrate that both the autoproteolysis and the digestion of HSP90, are similar to 
those obtained in endothelial cells. The calpain-1 activation is probably, at least in part, restricted 
by a recruitment of HSP90 from cytosol. Altogether the experimental evidences included in this 
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study converge towards the notion of an important role played by the calpain-1-containing 
protein complex in lipid rafts. Thus, we consider that these are promising basis to unravel the 
role of calpain-1 in lipid raft dysfunction, accompanied by intracellular Ca
2+
 dysregulation. The 
full characterization of the mechanisms related to the recruitment of HSP90, in order to prevent a 
massive digestion of calpain-1 potential substrates, following alteration in [Ca
2+
]i, requires 
further experiments to correlate the calpain-1 activity to the changes in protein composition of 
the lipid rafts and to better define the regulation of the calpain-1 activation at this site.  
It has been shown that neuronal intracellular Ca2+ signaling is abnormal in many 
neurodegenerative disorders including amyotrophic lateral sclerosis (ALS) [73]. Moreover lipid 
raft disturbances have been described in human motor neuron-like cells that express the mutated 
ALS protein SigR1 [74]. We have demonstrated previously that a transgenic mice model 
affected by amyotrophic lateral sclerosis shows elevation in [Ca
2+
]i and activation of calpain-1 in 
the central nervous system compared to control animals [75]. Hence in the next future we will 
explore the lipid raft-associated protein pattern in different tissues from these transgenic mice 
during the progression of the disease, and the consequent possible modification of cell signalling.  
All the experiments will be carried out also on the tissues obtained from age matched control 
animals. In fact, the critical role of calpain-1 in the early phase and during the progression of 
ALS, suggests that the characterization of change in the lipid raft composition could identify new 
therapeutic targets able to counteract the onset and fatal course of this disease. 
 
 
 
Note: Some of the data reported in this thesis have already been published: Ref. [76]. 
 
 
56 
 
6. REFERENCES  
1. Hosseini M, Najmabadi H, & Kahrizi K. Calpains: Diverse Functions but Enigmatic. 
Archives of Iranian Medicine (AIM), 2018; 21(4):170-179. 
2. Ono Y, Sorimachi H. Calpains – an elaborate proteolytic system. Biochim. Biophys. 
Acta. 2012;1824:224–236. 
3. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and 
physiological-pathological involvement. The FASEB Journal, 1994; 8(11): 814-822. 
4. Dutt P, Croall DE, Arthur SC, Veyra TD, Williams K, Elce JS, Greer PA. m-Calpain is 
required for preimplantation embryonic development in mice. BMC Dev. Biol., 2006; 
6:3. 
5. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier 
L, Devaud C, Pasturaud P, Roudaut C, Hillaire D, Passos-Bueno MR, Zats M, Tischfield 
JA, Fardeau M, Jackson CE, Cohen D, Beckmann JS. Mutations in the proteolytic 
enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 1995; 81:27-40. 
6. Dodson G; Wlodawer A. Catalytic triads and their relatives. Trends in Biochemical 
Sciences, 1998; 23:347–352. 
7. Berg JM, Tymoczko JL, Stryer L. Biochimica, Settima edizione, 2012; Zanichelli editore 
S.p.A., ISBN 978-88-08-19873-0 
8. Dainese E, Minafra R, Sabatucci A, Vachette P, Melloni E, Cozzani I. Conformational 
changes of calpain from human erythrocytes in the presence of Ca
2+
. J Biol Chem, 2002; 
277(43):40296-301. 
57 
 
9. Michetti M, Salamino F, Minafra R, Melloni E, Pontremoli S. Calcium-binding 
properties of human erythrocyte calpain. Biochem J, 1997; 325:721-726. 
10. Michetti M, Salamino F, Tedesco I, Averna M, Minafra R, Melloni E, Pontremoli S. 
Autolysis of human erythrocyte calpain produces two active enzyme forms with different 
cell localization. FEBS Lett, 1996; 392:11-15. 
11. Goll DE, Thompson VF, Li H, Wei W, Cong J. The Calpain System. Physiol Rev, 2003; 
83:731–801. 
12. Cheng Z, Jiang X, Pansuria M, Fang P, Mai J, Mallilankaraman K, Gandhirajan RK, 
Eguchi S, Scalia R, Madesh M, Yang X, Wang H. Hyperhomocysteinemia and 
hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation. 
Diabetes, 2015; 64(3):947-59. 
13. Gil-Parrado S, Popp O, Knoch TA, Zahler S, Bestvater F, Felgenträger M, Holloschi A, 
Fernández-Montalván A, Auerswald EA, Fritz H, Fuentes-Prior P, Machleidt W, Spiess 
E. Subcellular localization and in vivo subunit interactions of ubiquitous µ-calpain. J Biol 
Chem, 2003; 278(18):16336-46. 
14. Shiraha H, Glading A, Chou J, Jia Z, Wells A. Activation of m-calpain (calpain II) by 
epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. 
Mol Cell Biol, 2002; 22(8):2716-27. 
15. Todd B, Moore D, Deivanayagam CC, Lin GD, Chattopadhyay D, Maki M, Wang KK, 
Narayana SV. A structural model for the inhibition of calpain by calpastatin: crystal 
structures of the native domain VI of calpain and its complexes with calpastatin peptide 
and a small molecule inhibitor. J Mol Biol, 2003; 328(1):131-46. 
58 
 
16. Takano J, Watanabe M, Hitomi K, Maki M. Four types of calpastatin isoforms with 
distinct amino-terminal sequences are specified by alternative first exons and 
differentially expressed in mouse tissues. J Biochem, 2000; 128(1):83-92. 
17. De Tullio R, Averna M, Pedrazzi M, Sparatore B, Salamino F, Pontremoli S, Melloni E. 
Differential regulation of the calpain-calpastatin complex by the L-domain of calpastatin. 
Biochim Biophys Acta, 2014; 1843(11):2583-91. 
18. Melloni E, Averna M, Stifanese R, De Tullio R, Defranchi E, Salamino F, Pontremoli S. 
Association of calpastatin with inactive calpain: a novel mechanism to control the 
activation of the protease? J Biol Chem, 2006; 281(34):24945-54. 
19. De Tullio R, Franchi A, Martines A, Averna M, Pedrazzi M, Melloni E, Sparatore B. 
Unexpected role of the L-domain of calpastatin during the autoproteolytic activation of 
human erythrocyte calpain. Biosci Rep, 2018; 38(2). 
20. Rao MV, Campbell J, Palaniappan A, Kumar A, Nixon RA. Calpastatin inhibits motor 
neuron death and increases survival of hSOD1(G93A) mice. J Neurochem. 2016; 
137(2):253-65. 
21. Hood JL, Logan BB, Sinai AP, Brooks WH, Roszman TL. Association of the 
calpain/calpastatin network with subcellular organelles. Biochem Biophys Res Commun, 
2003; 310(4):1200-12. 
22. Averna M, Pellegrini M, Cervetto C, Pedrazzi M, Bavestrello M, De Tullio R, Salamino 
F, Pontremoli S, Melloni E. Physiological roles of calpain 1 associated to multiprotein 
NMDA receptor complex. PLoS One, 2015; 10(1):e0139750. 
23. Doshi S, Lynch DR. Calpain and the glutamatergic synapse. Front Biosci. 2009; 1:466-
76. 
59 
 
24. Averna M, De Tullio R, Pedrazzi M, Bavestrello M, Pellegrini M, Salamino F, 
Pontremoli S, Melloni E. Interaction between calpain-1 and HSP90: new insights into the 
regulation of localization and activity of the protease. PLoS One, 2015; 10(1):e0116738. 
25. Verma S, Goyal S, Jamal S, Singh A, Grover A. HSP90: Friends, clients and natural foes. 
Biochimie, 2016; 127:227–240. 
26. Averna M, Stifanese R, De Tullio R, Passalacqua M, Salamino F, Pontremoli S, Melloni 
E. Functional role of HSP90 complexes with endothelial nitric-oxide synthase (eNOS) 
and calpain on nitric oxide generation in endothelial cells. J Biol Chem. 2008; 
283(43):29069-76. 
27. Averna M, Stifanese R, De Tullio R, Salamino F, Bertuccio M, Pontremoli S, Melloni E. 
Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the 
expression levels of HSP90. FEBS J. 2007; 274(23):6116-27. 
28. Averna M, Stifanese R, De Tullio R, Salamino F, Pontremoli S, Melloni E. In vivo 
degradation of nitric oxide synthase (NOS) and heat shock protein 90 (HSP90) by calpain 
is modulated by the formation of a NOS-HSP90 heterocomplex. FEBS J. 2008; 
275(10):2501-11. 
29. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring 
enzyme. Proc Natl Acad Sci U S A. 1990; 87(2):682-5. 
30. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994; 
298:249-58. 
31. Liu H, Li J, Zhao F, Wang H, Qu Y, Mu D. Nitric oxide synthase in hypoxic or ischemic 
brain injury. Rev Neurosci. 2015; 26(1):105-17. 
60 
 
32. Mineo C, Shaul PW. Regulation of eNOS in caveolae. Adv Exp Med Biol. 2012; 729:51-
62. 
33. Ju H, Zou R, Venema VJ, Venema RC. Direct interaction of endothelial nitric-oxide 
synthase and caveolin-1 inhibits synthase activity. J Biol Chem. 1997; 272(30):18522-5. 
34. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health 
and disease.  Physiol Rev. 2004; 84(4):1341-79. 
35. Pani B, Singh BB. Lipid rafts/caveolae as microdomains of calcium signaling. Cell 
Calcium. 2009; 45(6):625-33  
36. Isshiki M, Anderson RG. Function of caveolae in Ca2+ entry and Ca2+-dependent signal 
transduction. Traffic. 2003; 4(11):717-23. 
37. Goligorsky MS, Li H, Brodsky S, Chen J. Relationships between caveolae and eNOS: 
everything in proximity and the proximity of everything. Am J Physiol Renal Physiol. 
2002; 283(1):F1-10. 
38. Colin J, Gregory-Pauron L, Lanhers MC, Claudepierre T, Corbier C, Yen FT, Malaplate-
Armand C, Oster T. Membrane raft domains and remodeling in aging brain. Biochimie. 
2016; 130:178-187. 
39. Robinson LE, Shridar M, Smith P, Murrell-Lagnado RD. Plasma membrane cholesterol 
as a regulator of human and rodent P2X7 receptor activation and sensitization. J Biol 
Chem. 2014; 289(46):31983-94. 
40. Morford LA, Forrest K, Logan B, Overstreet LK, Goebel J, Brooks WH, Roszman TL. 
Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells. 
Biochem Biophys Res Commun. 2002; 295(2):540-6. 
61 
 
41. Goudenege S, Dargelos E, Claverol S, Bonneu M, Cottin P, Poussard S. Comparative 
proteomic analysis of myotube caveolae after milli-calpain deregulation. Proteomics. 
2007; 7(18):3289-98.  
42. Song KS, Li Shengwen, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-
purification and direct interaction of Ras with caveolin, an integral membrane protein of 
caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol 
Chem. 1996; 271(16):9690-7. 
43. Macdonald JL, Pike LJ. A simplified method for the preparation of detergent-free lipid 
rafts.  J Lipid Res. 2005; 46(5):1061-7. 
44. Smart EJ, Ying YS, Mineo C, Anderson RG. A detergent-free method for purifying 
caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA. 1995; 
92(22):10104-8. 
45. Persaud-Sawin DA, Lightcap S, Harry GJ. Isolation of rafts from mouse brain tissue by a 
detergent-free method. J Lipid Res. 2009; 50(4):759-67. 
46. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin 
phenol reagent. J Biol Chem. 1951; 193(1):265-75.  
47. Laemmli UK. Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature. 1970; 227(5259):680-5. 
48. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 
Biotechnology. 1992; 24:145-9. 
49. Repetto G, Del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell 
viability/cytotoxicity. Nat Protoc. 2008; 3(7):1125-31. 
62 
 
50. Stalker TJ, Skvarka CB, Scalia R. A novel role for calpains in the endothelial dysfunction 
of hyperglycemia. FASEB J. 2003; 17:1511-1513. 
51. Smolock AR, Mishra G, Eguchi K, Eguchi S, Scalia R. Protein kinase C upregulates 
intercellular adhesion molecule-1 and leukocyte-endothelium interactions in 
hyperglycemia via activation of endothelial expressed calpain. Arterioscler. Thromb. 
Vasc. Biol. 2010; 31:289-296. 
52. Buraczynska M, Wacinski P, Stec A, Kuczmaszewska A. Calpain-10 gene 
polymorphisms in Type 2 diabetes and its micro- and macrovascular complications. J. 
Diabetes Complicat. 2013; 27:54-58.  
53. Chen B, Zhao Q, Ni R, Tang F, Shan L, Cepinskas I, Cepinskas G, Wang W,  Schiller 
PW, Peng T. Inhibition of calpain reduces oxidative stress and attenuates endothelial 
dysfunction in diabetes. Cardiovasc. Diabetol. 2014; 13:88. 
54. Pandurangan M, Hwang I, Orhirbat C, Jieun Y, Cho SH. The calpain system and 
diabetes. Pathophysiology 2014; 21:161-167. 
55. Pànico P, Salazar AM, Burns AL, Ostrosky-Wegman P. Role of calpain-10 in the 
development of diabetes mellitus and its complications. Arch. Med. Res. 2014; 45:103-
115. 
56. Prangsaengtong O, Senda K, Doki Y, Park JY, Jo M, Sakurai H, Shibahara N, Saiki I, 
Koizumi K. Calpain 1 and -2 play opposite roles in cord formation of lymphatic 
endothelial cells via eNOS regulation. Hum Cell. 2012; 25(2):36-44. 
57. Wang Y, Briz V, Chishti A, Bi X, Baudry M. Distinct roles for μ-calpain and m-calpain 
in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated 
neurodegeneration. J Neurosci. 2013; 33(48):18880-92. 
63 
 
58. Wang Y, Lopez D, Davey PG, Cameron DJ, Nguyen K, Tran J, Marquez E, Liu Y, Bi X, 
Baudry M. Calpain-1 and calpain-2 play opposite roles in retinal ganglion cell 
degeneration induced by retinal ischemia/reperfusion injury. Neurobiol Dis. 2016; 
93:121-8. 
59. Delint-Ramírez I, Salcedo-Tello P, Bermudez-Rattoni F. Spatial memory formation 
induces recruitment of NMDA receptor and PSD-95 to synaptic lipid rafts. J Neurochem. 
2008; 106(4):1658-68. 
60. Ponce J, de la Ossa NP, Hurtado O, Millan M, Arenillas JF, Dávalos A, Gasull T. 
Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-
mediated effect in neuroprotection. Stroke. 2008; 39(4):1269-75. 
61. Sierra-Valdez FJ, Ruiz-Suárez JC, Delint-Ramirez I. Pentobarbital modifies the lipid raft-
protein interaction: A first clue about the anesthesia mechanism on NMDA and GABAA 
receptors. Biochim Biophys Acta. 2016; 1858(11):2603-2610. 
62. Shastry P, Basu A, Rajadhyaksha MS. Neuroblastoma cell lines - a versatile in vitro 
model in neurobiology. Int J Neurosci. 2001; 108(1-2):109-26. 
63. Zhao YL, Song JN, Zhang M. Role of caveolin-1 in the biology of the blood-brain 
barrier. Rev Neurosci. 2014; 25(2):247-54. 
64. Irwin ME, Mueller KL, Bohin N, Ge Y, Boerner JL. Lipid raft localization of EGFR 
alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell 
Physiol. 2011; 226(9):2316-28. 
65. Ge Y, Fan F, Didion SP, Roman RJ. Impaired myogenic response of the afferent arteriole 
contributes to the increased susceptibility to renal disease in Milan normotensive rats. 
Physiol. Rep. 2017; 5(3).  
64 
 
66. Linde CI, Karashima E, Raina H, Zulian A, Wier WG, Hamlyn JM, Ferrari P, Blaustein 
MP, Golovina VA. Increased arterial smooth muscle Ca
2+
 signaling, vasoconstriction, 
and myogenic reactivity in Milan hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 
2012; 302:H611-620. 
67. Averna M, Stifanese R, De Tullio R, Passalacqua M, Defranchi E, Salamino F, Melloni 
E, Pontremoli S. Regulation of calpain activity in rat brain with altered Ca
2+
 homeostasis. 
J. Biol. Chem. 2007; 282:2656-2665. 
68. Tompa P, Buzder-Lantos P, Tantos A, Farkas A, Szilágyi A, Bánóczi Z, Hudecz F, 
Friedrich P. On the sequential determinants of calpain cleavage. J Biol Chem. 2004; 
279(20):20775-85. 
69. Lichtenberg D, Goñi FM, Heerklotzc H. Detergent-resistant membranes should not be 
identified with membrane rafts. TIBS. 2005 30: 430-436 
70. Mohamed A Shah AD1, Chen D, Hill MM, RaftProt V2: understanding membrane 
microdomain function through lipid raft proteomes. Nucleic Acids Res. 2018. doi: 
10.1093/nar/gky948. 
71. Etwebi Z, Landesberg G, Preston K, Eguchi S, Scalia R. Mechanistic Role of the 
Calcium-Dependent Protease Calpain in the Endothelial Dysfunction Induced by MPO 
(Myeloperoxidase). Hypertension. 2018; 71(4):761-770. 
72. Zhang Y, Liu NM, Wang Y, Youn JY, Cai H. Endothelial cell calpain as a critical 
modulator of angiogenesis. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(6):1326-
1335. 
73. Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol Med 
2009; 15: 89–100. 
65 
 
74. Vollrath JT, Sechi A, Dreser A, Katona I, Wiemuth D, Vervoorts J, Dohmen M, 
Chandrasekar A, Prause J, Brauers E, Jesse CM, Weis J, Goswami A.Loss of function of 
the ALS protein SigR1 leads to ER pathology associated with defective autophagy and 
lipid raft disturbances. Cell Death Dis. 2014; 5:e1290. 
75. Stifanese R, Averna M, De Tullio R, Pedrazzi M, Milanese M, Bonifacino T, Bonanno G, 
Salamino F, Pontremoli S, Melloni E. Role of calpain-1 in the early phase of 
experimental ALS. Arch Biochem Biophys. 2014; 562:1-8. 
76. Martines A, Stifanese R, Faelli EL, Perasso L, Melloni I, Ruggeri P, Averna M. Calpain-
1 resident in lipid raft/caveolin-1 membrane microdomains plays a protective role in 
endothelial cells. Biochimie. 2017; 133:20-27. 
